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Studies in the role of microRNAs in class switch recombination, and the role of TLR9 
complex antigens in shaping the germinal center response 
Eric Wigton 
Abstract 
The studies in this work are centered around two projects.  The first two chapters are 
composed of background and primary research on the role of microRNAs (miRNAs) in B cell 
class switch recombination.  MiRNAs regulate cell fate decisions by post-transcriptionally tuning 
networks of mRNA targets. We utilized miRNA-directed pathway discovery to reveal a regulatory 
circuit that influences B cell activation and immunoglobulin class switch recombination (CSR). 
We developed a system to deplete mature, activated B cells of miRNAs, and performed a rescue 
screen that identified the miR-221/222 family as a positive regulator of CSR. Endogenous miR-
221/222 regulated B cell proliferation and CSR to IgE and IgG1 in vitro, and miR-221/222-
deficient mice exhibited defective IgE production in allergic airway challenge and polyclonal B 
cell activation models in vivo. We combined comparative Ago2-HITS-CLIP and gene expression 
analyses to identify mRNAs bound and regulated by miR-221/222 in primary B cells. Interrogation 
of these putative direct targets uncovered functionally relevant downstream genes. Genetic 
depletion or pharmacological inhibition of Foxp1 and Arid1a confirmed their roles as key 
modulators of CSR to IgE and IgG1. The third chapter is in the study of TLR9 co-signaling in the 
germinal center (GC) B cell response.  It was previously unknown how co-signaling events through 
innate immune system receptors in B cells positively influenced the generation of GC B cells.  In 
this chapter we addressed this question through transcriptomics to find that signaling and activation 
from TLR9-containing antigen increased Myc and mTORC signatures that bolstered the GC B cell 
response. 
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Chapter One:  Non-coding RNAs in B cell biology 
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The purpose of this chapter is to outline recent work in the field of non-coding RNAs 
(ncRNAs) as it pertains to B cell biology.  A majority of the chapter is focused on how microRNAs 
(miRNAs) and long ncRNAs (lncRNAs), play pivotal roles in B cell activation and terminal 
effector functions.  While extensive reviews exist for individual aspects of miRNA’s role in B cell 
development and lymphomagenesis (Coffre and Koralov, 2017; Zheng et al., 2018), B cell 
responses (Cyster and Allen, 2019), and the molecular regulation of class switch recombination 
(CSR) (Yewdell and Chaudhuri, 2017; Yu and Lieber, 2019). This chapter highlights some of the 
key recent findings from primary studies and refers the reader to current in-depth reviews on these 
individual topics.  The focus of this review is on B cell activation and CSR regulation by ncRNAs. 
The role of ncRNAs on B cell biology is extensive and the thousands of work hours that has gone 
into elucidating these processes is both breathtaking and inspiring.  
Introduction to B cells 
B cells form the humoral branch of the adaptive immune system and are key drivers in 
defending the host through immunological memory and antibody production.  The complex life 
span of B cells requires distinct developmental checkpoints beginning with early development and 
lineage commitment in the bone marrow followed by migration to and maturity in secondary 
lymphoid organs like the spleen and peripheral lymph nodes (Ramirez et al., 2010).  The entire 
process requires strict transcriptional and migratory cues.  These mature cells are poised to respond 
directly to pathogens through engagement of their antigen B cell receptor (BCR) as well as pattern 
recognition receptors (PRRs) such as the Toll like receptors (TLRs) to a broad range of pathogenic 
stimuli.  Antigen receptor stimulated responses can be in a T-independent (TI) fashion, where B 
cells expand rapidly and generate low affinity pathogen specific IgM (Cyster and Allen, 2019).  
The responses can also be T-dependent (TD), whereby activated cells enter the microanatomical 
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space of the germinal center (GC), and iteratively cycle between antigen receptor mutating and 
proliferating centroblasts in the dark zone (DZ), that then migrate to the light zone (LZ) as 
centrocytes where they are selected through pro-survival cues from T follicular helper (Tfh) cell 
stimulus  (Cyster and Allen, 2019; Mesin et al., 2016).  Through this process long-term 
immunological memory is established, and high affinity antibodies are produced against a specific 
pathogen or antigen.  
Introduction to miRNAs  
Initially discovered in C. elegans, miRNAs are small 18-22nt RNAs that destabilize protein 
coding mRNAs (Lee et al., 1993).  Canonical miRNAs are transcribed as long pri-miRNA hairpins 
that require processing by Drosha/Dgcr8 in the nucleus to short hairpin pre-miRNAs that are 
exported from the nucleus, and further processed by Dicer to miRNA duplexes which are loaded 
into Argonaute proteins (O'Brien et al., 2018). MiRNAs guide the Argonaute (Ago) protein-
containing miRNA-induced silencing complex (RISC) to the 3’UTR of target mRNAs via 
complementary base pairing (Bartel, 2004). Families of miRNAs with shared target repertoires are 
defined by their ‘seed sequence’ (nucleotides 2-8 from the 5’ end of the mature miRNA), which is 
the major determinant of target recognition, while 3’ ends of the miRNAs may contribute partially 
to target recognition (Bartel, 2004; Broughton et al., 2016). The miRISC mediates translational 
inhibition and destabilization of bound mRNAs (Jonas and Izaurralde, 2015). Individual miRNAs 
and their family members can target hundreds of unique transcripts and thereby regulate large gene 
networks in a manner specific to cellular context and gene expression program. 
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MiRNAs in early B cell development. 
MiRNAs are indispensable for early B cell programming from the pro-B to pre-B stage, as 
ablation of miRNA processing machinery leads to complete block at this developmental stage 
(Brandl et al., 2016; Coffre and Koralov, 2017; Koralov et al., 2008).  During this stage of 
development, B cells undergo VDJ recombination, a form of combinatorial DNA mutation to 
produce a unique antigen receptor in each developing B cell.  Dysregulation of miRNA biogenesis 
at this stage leads to increased apoptosis, and an inability to form functional BCRs.  Furthermore 
studies have implicated individual miRNAs that are necessary for key developmental checkpoints 
in the B cell lineage commitment and their dysregulation can lead to transformation and 
leukemia/lymphomagenesis phenotypes (Coffre and Koralov, 2017; de Yebenes et al., 2013; 
Zheng et al., 2018).   
Endogenous miRNA biogenesis is also important for B cell maturation. CD19-cre 
mediated Dicer ablation leads to dysfunctional B cell selection and the generation of autoimmunity 
with lupus like disease and a skewing of the Ig repertoire towards a multitude of self-antigens 
(Belver et al., 2010).  The developmental fate decision for mature B cells to commit to the  
marginal zone compartment over the follicular compartment is also mediated by control of 
miR146a (King et al., 2016). 
MiRNAs in B cell activation, GC and PC development 
In the context of acute activation, naive B cells undergo profound metabolic restructuring 
(Akkaya et al., 2018; Waters et al., 2018), poising these cells to rapidly proliferate, and undergo 
transcriptional changes.  The miRNA landscape of activated B cells  drastically changes from their 
naïve counterparts, as miRNAs are dynamically regulated to modulate the gene expression changes 
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necessary for such rapid cellular responses (Fowler et al., 2015; Kuchen et al., 2010).  Deletion of 
Dicer at the GC/PC commitment stage (utilizing Aicda-Cre) leads to a profound defect in humoral 
immunity through decreased GC cells and PCs and isotype switched antibodies in response to 
immunization (Xu et al., 2012). 
Multiple miRNAs regulate the activation of B cells, with miR-155 as a keystone regulator 
of B cell activation and terminal cell differentiation and transformation (Figure 1.1). Originally 
discovered as B cell integration cluster or (bic), the primary transcript from which miR-155 is 
processed is one of the most highly upregulated transcripts upon B cell activation (Clurman and 
Hayward, 1989). This miRNA has been shown to directly regulate GC and PC differentiation 
(Rodriguez et al., 2007; Thai et al., 2007; Vigorito et al., 2007), including promoting cell cycle 
(Arbore et al., 2019), regulating apoptosis (Nakagawa et al., 2016), and directly targeting AID and 
DNA mutation associated with CSR (Dorsett et al., 2008; Teng et al., 2008).  Additionally, these 
studies are some of the only to mutate seed binding sites in 3’UTRs of target genes to test if single 
miRNA:target downregulation confers intermediate phenotypes to miRNA ablation, and in the 
case of miR-155 both AID seed match site (Dorsett et al., 2008; Teng et al., 2008) and PU.1 (Lu 
et al., 2014) seed match site mutation conferred an intermediate effect of miR-155 KO mice. The 
multitude of processes and mRNA targets regulated by miR-155 provide direct evidence for gene 
network mechanism of action and demonstrate the promiscuity with which a single miRNA can 
target multiple genes simultaneously in a cell fate dependent fashion. 
 In terms of B cell activation, recent studies have demonstrated a novel interplay of miRNA 
mediated regulation of metabolism (Jiang et al., 2018), and the converse of metabolite regulation 
of miRNA expression (Sanchez et al., 2020).  The Let-7adf miRNA cluster represses T-
independent B cell responses through metabolic regulation (Jiang et al., 2018).  This miRNA 
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cluster directly targeted hexokinase-2 and glutamine transporter Slc1a5 to limit glycolysis and 
glutamine uptake, ultimately repressing c-Myc protein expression in response to both antigen and 
lipopolysaccharide stimulation of B cells.  Mice with a B cell specific deficiency in this miRNA 
cluster showed increased antibody responses to T-independent immunizations, linking this 
metabolic control to the T-independent PC fate decision.  Further evidence has directly linked 
metabolites as regulators of miRNA expression in B cells (Sanchez et al., 2020).  Epigenetic 
changes elicited by short chain fatty acid metabolites butyrate and propionate in B cells 
upregulated miRNAs which in turn modulate Aicda and Prdm1 and affect PC fate decisions and 
auto-antibody production.  B cell activation has been shown to induce rapid metabolic changes 
(Waters et al., 2018) and recently GC B cells have been shown to utilize fatty acid oxidation over 
glycolysis (Weisel et al., 2020). Dynamic inter-regulation of miRNAs and metabolism in B cells 
in the context of fate decisions require further study.   
 The miRNA cluster miR-17~92 plays a key role in regulating PC development, migration 
to the bone marrow and isotype specific antibody production (Xu et al., 2015).  Mice with germline 
deficiency in this miRNA have a profound pro-B to pre-B development block (Koralov et al., 
2008; Ventura et al., 2008) .  However, utilizing CD19-cre to ablate this cluster later in 
development leads to dysregulated B cell selection, central tolerance and autoimmunity (Lai et al., 
2016).  Deletion at this stage also leads to defects in IgG2c antibody titers and enhanced PC 
migration to the bone marrow, related to targeting of Ikaros and S1pr1, respectively (Xu et al., 
2015).  Further studies have implicated this miRNA as being necessary for immune responses 
driving graft vs host disease in both a T and B cell intrinsic fashions (Wu et al., 2018), and its 
overexpression can lead to lymphoproliferative disease (Dal Bo et al., 2015).      
7 
 
 Direct intercellular transfer of miRNAs has been recently implicated as positively 
regulating the GC B cell response (Fernandez-Messina et al., 2020).  Rab27-dependent 
extracellular micro-vesicle miRNA transfer of miR20a-5p, miR‐25‐3p, and miR‐155‐3p from Tfh 
cells to GC B cells was necessary for optimal GC B cell responses in vivo. Extracellular micro-
vesicle transfer was relayed through the immune synapse formed between activated GC:Tfh cells 
during positive selection in the LZ and altered the LZ/DZ phenotype of the GC.  Given that there 
are diverse cargos of other ncRNAs beyond miRNAs in the extracellular vesicles generated from 
activated T cells (Chiou et al., 2018), other non-miRNA species’ transfer could influence these 
GC:Tfh cellular interactions and dynamics and require further study. 
The role of ncRNAs in class switch recombination 
miRNAs 
The process of CSR, whereby B cells mutate constant regions of the heavy chain locus Igh, 
confers specific isotype-specific biological activity to the BCR and corresponding antibodies.  This 
process requires active transcription in the Igh locus and the deaminase AID (Yewdell and 
Chaudhuri, 2017; Yu and Lieber, 2019).  Several miRNAs directly regulate AID including miR-
181b in mouse (de Yebenes et al., 2008), miR-29b in human (Recaldin et al., 2018), and miR-155-
3p (Dorsett et al., 2008; Teng et al., 2008; Vigorito et al., 2007) in both (Figure 1.1).  Our recent 
study further implicated miR-221/222 as regulators of CSR to IgG1 and IgE by a gene network 
regulation including Arid1a and Foxp1. 
Germline Igh transcripts 
  Beyond miRNAs that directly regulate cellular functions necessary for CSR, ncRNA from 
active germline transcription (GLT) at switch (S) regions in the Igh locus have been shown to form 
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stable RNA:DNA hybrids known as R loops and further DNA and RNA G quadraplexes (G4) 
(Pavri, 2017; Roy et al., 2008; Yewdell and Chaudhuri, 2017; Yu and Lieber, 2019).  The role of 
these R loops has been implicated as a mode of structural conformation stability allowing the 
targeting of the AID enzyme to single stranded DNA exposed during transcription (Yu and Lieber, 
2019) (Figure 1.2).  It had been postulated that R loops were necessary for AID recruitment as 
inversion of Sγ1 region in mice that profoundly reduced R loop formation concordantly reduced 
B cell CSR to IgG1 (Shinkura et al., 2003).  However a recent study demonstrated that R loops are 
not required for AID mediated mutagenesis, as a transgenic mouse in which the Igv region was 
replaced with a core S region in either physiological or reverse orientation showed equivalent AID 
mutation rates in both cases (Yeap et al., 2015).  These two studies together implicate that the 
frequency of R loops in the Igh region are correlated to CSR but not necessarily to AID 
recruitment, hinting that R loops could be a transient structural phenomenon.  These studies were 
complemented by the finding that RNAse H overexpression in B cells, which rapidly digests R 
loops, led to an increase in AID mutations in the Igh locus and minimally decreased the frequency 
of CSR (Maul et al., 2017).  Taken together, these studies showed that the physiological orientation 
of transcription in the Igh locus is necessary for R loop initiation, while prolonged R loop 
formation in this region is not necessary. 
 Recent protein crystallization studies have shown that AID binds directly to DNA G4 
structures as a substrate (Qiao et al., 2017) , a motif that results in guanine rich regions of the non-
template ssDNA during transcription in the Igh S regions.  Thus it appears that DNA G4 structures 
are the main substrate for AID recruitment, and R loops are only necessary in that they facilitate 
DNA G4 structures on non-template DNA strands.  However, RNA G4 structures arising from 
GLT processing and intronic lariat debranching can serve as an AID substrate as well (Zheng et 
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al., 2015). Whereby, limiting the production of these RNA G4 substrates by ablating the lariat 
debranching enzyme, Dbr1 to heterozygous levels in mice reduced CSR.  Furthermore, it has 
recently been supported that these RNA G4 AID substrates must be processed by RNA helicase 
DDX1 to facilitate AID localization (Ribeiro de Almeida et al., 2018).  While genetic ablation of 
mediators of these processing events diminished CSR frequency, they did not completely abolish 
it, indicating redundancy with other mechanism of AID recruitment like interactions with RNA 
polymerase II and other parts of the core transcriptional machinery (Nambu et al., 2003; Pavri et 
al., 2010).  DNA G4 structures arising from R loop formation also serve as replication origin 
binding sites, plausibly facilitating CSR beyond an AID directing mechanism and through 
promotion of DNA replication events (Wiedemann et al., 2016).   Without physiologically oriented 
GLT, CSR is fundamentally impaired, however the full extent to which these GLTs are processed 
and the mechanistic action they have on recruiting AID and other proteins to S regions to facilitate 
DNA breaks requires further study.     
Long noncoding RNAs 
 Additional lncRNAs have also been implicated in controlling isotype specific CSR  
(Pefanis et al., 2014; Pefanis et al., 2015; Rothschild et al., 2020).  It is well established that 
lncRNAs can modulate chromatin and act as enhancers for other genes (Nair et al., 2020). In a 
recent study, a newfound lncRNA-CSRIgA and 2 other RNA expressing elements were elucidated 
megabases downstream of the Igh coding region (Rothschild et al., 2020). B cells isolated from a 
mouse model lacking transcription of lncRNA-CSRIgA fail to undergo normal levels of CSR to 
IgA and IgG2b in vitro and to IgA in Peyer’s patches. lncRNA-CSRIgA was necessary for 
coordination of regulatory proteins to nearby CTCF sites that orchestrated long range chromatin 
changes and interactions with the 3’ region of the Igh  locus. Chromatin loop extrusion by a CTCF 
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and cohesin-dependent mechanism is necessary for the physical orientation and organization of S 
sites and efficient CSR (Zhang et al., 2019). It could be that regulation of CTCF/cohesin binding 
in the lncRNA locus also modulates chromatin loop extrusion in the neighboring Igh locus as well.  
The epigenetic regulation of multiple topologically associated domains of chromatin interacting 
through active transcription of a lncRNA is an interesting mechanism of gene regulation, and the 
influence of this process on other sites of the genome will require further study. 
Concluding remarks  
 The role of ncRNAs can be broken into three main groups of action - miRNA mediated 
gene network control and regulation of cell state specific gene targets in B cell maturation and 
activation, R-loop mediated regulation of CSR, and lncRNA mediate topological associated 
domain regulation in chromatin epigenetics.  While miRNAs have been extensively studied, there 
is more to glean from studying cell type and state-specific miRNA:target networks as a means of 
discovering novel genes and pathways that control their unique biology.  Furthermore the 
improvement of RNA-Cross-linking-Immunoprecipitation techniques will further provide global 
maps of miRNA binding.  The multivariate roles of lncRNAs as miRNA sponges (Karreth et al., 
2015), protein interacting substrates (such as RNA G4 substrates for AID), and epigenetic 
regulators (as in the case of lncRNAIgA) are a new horizon by which these ncRNAs dictate cellular 
function. 
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Figure 1.1:  Schematic of B cell activation, fate decisions, and miRNAs that influence these 
processes. 
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Figure 1.2: Schematic of R-loop mediated mechanisms of Switch region chromatin 
remodeling and AID recruitment. 
A. Model by which active transcription complex guides AID directly to G4 DNA duplexes created 
from R-loop stabilization of the Switch region.  B.  Model by which the germline transcript (GLT) 
of the Switch region is processed to form RNA G4 complexes, which bind AID and provide 
sequence homology to Switch region sites whereby AID can bind G4 DNA duplexes. C. Model 
where in addition to GLT processing from B, DDX1 helicase activity is necessary for converting 
RNA G4 substrates into R-loops that releases AID to bind to DNA G4 substrates.  
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Introduction 
MicroRNAs have been leveraged as discovery tools to elucidate genes and pathways that 
regulate lymphocyte fate and function in immunity. Rescue screens in miRNA-deficient T cells 
uncovered specific miRNAs that influence cytokine production (Pua et al., 2016; Steiner et al., 
2011). Algorithms that use seed sequence matching and other 3’ UTR sequence features are used 
to predict target gene networks (Agarwal et al., 2015), and these networks can be further filtered 
for miRNA effects on gene expression in the appropriate cellular context (Pua et al., 2016). Ago-
2 high-throughput sequencing of RNA isolated by crosslinking immunoprecipitation (Ago2-HITS-
CLIP) provides context-specific biochemical evidence for miRISC occupancy of potential target 
sites, and comparing Ago2-HITS-CLIP in miRNA-deficient and -sufficient cells facilitates 
mapping of specific miRNA:target interactions (Chi et al., 2009; Gagnon et al., 2019; Loeb et al., 
2012). Functional interrogation of these targets can unearth regulatory genes and pathways 
previously unknown to be important to biological processes of interest and direct researchers to 
novel therapeutic targets. 
Hyper-production of antibodies of the IgE isotype is a hallmark of allergy (Hu et al., 2018).  
IgE is directly involved in the pathogenesis of asthma and other allergic diseases, as it arms mast 
cells and basophils for rapid allergen-specific inflammatory responses (Galli and Tsai, 2012). 
Omalizumab, an approved therapeutic antibody that targets IgE, reduces asthma exacerbations in 
a subset of patients (Busse et al., 2001). It has been suggested that therapies that target or reduce 
the generation of IgE-producing B cells may provide better protection against symptoms of allergic 
diseases (Hu et al., 2018). The generation of IgE producing B cells from naïve B cells requires the 
induction of Immunoglobulin class switch recombination (CSR), a process of somatic DNA 
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mutation and recombination that preserves the B cell’s antibody specificity while switching the 
isotype of its heavy chain (Yewdell and Chaudhuri, 2017; Yu and Lieber, 2019).   
CSR requires multiple coordinated processes starting with active transcription driven by 
cytokine signaling (Stavnezer and Schrader, 2014), expression and regulation of the activation 
induced deaminase enzyme AID, DNA repair, (Yu and Lieber, 2019), and distinct regulation of 
cell cycle and proliferation (Hodgkin et al., 1996).  AID is directly regulated by miRNAs, 
specifically miR-155 (Dorsett et al., 2008; Teng et al., 2008; Vigorito et al., 2007).  CSR to IgG1 
and IgE isotypes require IL-4 signaling (Finkelman et al., 1990; Kopf et al., 1993; Kuhn et al., 
1991).  Signaling from T follicular helper cells through CD40, and other cytokines also influence 
this process. 
 In this study, we developed a mouse model system to ablate miRNA processing in mature 
B cells, and then performed a rescue screen for miRNAs that regulate CSR. This screen identified 
miR-221/222, a miRNA family previously unstudied in mature, nonmalignant B cells, as a positive 
regulator of this process (Knoll et al., 2013; Lupini et al., 2013; Petkau et al., 2018). We 
characterized miR221/222-deficient B cells from gene-targeted mice in vitro and in vivo, and 
empirically defined direct targets of these miRNAs in B cells through a combination of 
bioinformatic, biochemical and gene expression analyses. MiR-221/222 promoted CSR and B cell 
proliferation in vitro, IgE production in an allergic airway hypersensitivity model, and IgE+ 
plasmablast generation in a model of global B cell activation.  Among the plausible direct targets 
of miR-221/222, we uncovered Foxp1, Arid1a, and Cd164 as novel regulators of CSR. Together, 
these findings establish miR-221/222 as a regulator of B cell production of antibodies associated 
with allergy and asthma and provide insight into new regulators of CSR. 
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Materials and Methods  
Mice 
Mice used in this work included Cγ1-cre, B6.129P2(Cg)-Ighg1tm1(cre)Cgn/J  (Casola et al., 2006); 
CD21-cre, (Kraus et al., 2004); Dgcr8fl/fl, B6.Cg-Dgcr8tm1.1Blel/J (Rao et al., 2009); R26-LSL-YFP, 
B6.Gt(ROSA)26Sortm1(EYFP)Cos/J (Srinivas et al., 2001), CreERT2, B6.Cg-Ndor1Tg(UBC-cre/ERT2)1Ejb/1J 
(Ruzankina et al., 2007); Foxp1fl/fl, Foxp1tm1.1Pwt/J (Feng et al., 2010); Arid1afl/fl, 129.Arid1atm1.1Zhwa/J (Gao 
et al., 2008); and flox: mirc50fl/y or Δ: micr50-/y generated in this study.  Only male mice were used for miR-
221/222 deletion experiments, except some female mice were used for creating the Ago2-HITS-CLIP 
libraries.  For Foxp1 deletion, CreERT2Foxp1fl/fl R26-LSL-YFP mice have been previously described (Feng 
et al., 2011). For CD21-cre mediated Arid1afl/fl genetic deletion experiments, B6.129 N1 Arid1a-Het and 
Arid1a-WT mice were used, and B6.129 N2 Het and Cre+WT mice were used.  All mice were used between 
6-16 weeks for all strains, and all were age/sex matched for all other strains.  All mice were cared for and 
experimented on under the guidance/compliance of UCSF and UAB Laboratory Animal Research Centers 
and IACUC guidelines. 
B cell isolation, transfection and stimulation 
Splenic naive B cells were isolated using Dynabead untouched B cell (CD43 negative 
selection kit, Thermo Fisher) and stimulated in RPMI 1640 supplemented with 10% FCS, HEPES, 
2-mercaptoethanol, and L-glutamine.  Pre-transfection stimulation consisted of 250 ng/mL anti-
CD180 (RP105) (Biolegend) and 1 ng/ml IL-4 (recombinant mouse, Peprotech) at 106 cells/mL in 
12 well plates (Costar) for transfection conditions.  After 48hrs cells were washed 2x PBS and 
resuspended at 105 cells/10 µl in Neon transfection buffer R (Invitrogen) and mixed with siRNA 
(Dharmacon/GE), miRNA mimic (Dharmacon/GE), and/or luciferase plasmid before being 
immediately electroporated 3 x 10 ms at 1550 V on a Neon transfection instrument.  The 10 µl 
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transfection was then transferred directly into 200 µl of CSR media in a round bottom 96 well plate 
(Costar).  For CSR conditions cells were stimulated with 3µg/ml LPS (from Salmonella, Sigma) 
and 25 ng/ml IL-4 for miRNA and siRNA screens, or in 500 ng/ml-1µg/ml anti-CD40 (FGK45.1.1, 
Miltenyi), 25ng/ml IL-4 and 10-12.5 ng/ml IL-21 (eBioscience) at 105 cells/200 µl/ well in a 96 
well round bottom plate for Ago-2-HITS-CLIP library generation or flow cytometry.  For the 
ARID1A-BAF complex chemical inhibitor assay, cells were stimulated with BRD-K80443127 
dissolved in DMSO at reported concentration or vehicle alone.  
Foxp1 deletion and CD40LB feeder cell stimulation 
For Foxp1 deletion, CreERT2Foxp1fl/fl R26-LSL-YFP (Foxp1-KO), CreERT2Foxp1wt/wt R26-LSL-
YFP  (Foxp1-WT) mice were immunized 4 days consecutively (Day 0-3) with 3 mg/day tamoxifen (Sigma) 
i.p. dissolved in corn oil (20 mg/mL), rested for one day (Day 4). CD40L-Baff 3T3 feeder cells (Nojima et 
al., 2011) that were plated 2x105 in 24 well culture treated plates on Day 4.  Spleens were harvested on Day 
5 and follicular B cells that underwent cre-mediated recombination were FACS sorted (CD3-, CD19+, 
CD21/35 low, CD23+, YFP+) and  co-cultured at 2 x105 B cells/well with pre-coated CD40L-Baff 3T3 
feeder cells with and without IL-4 for 4 days (Day 9). 
RNA isolation, qPCR, and RNA-sequencing 
Stimulated B cells were pelleted, and RNA was extracted using TRIZOL reagent (Thermo 
Fisher).  RNA was extracted using a RNeasy micro kit (Qiagen).  cDNA was generated with one 
step miRX (Takara) for miRNA quantification or with super script III reverse transcription (SSIII) 
poly-dT first strand synthesis (Thermo Fisher) for Dgcr8 quantification.  miRNA primers for the 
miRX qPCR consisted of the full, mature miRNA sequence.  Primers for Dgcr8 were previously 
reported (Bronevetsky et al., 2013). qPCR cycle was a two-step cycle at 95C for 10 secs 60C for 
15 secs for 40 cycles and amplification was read out by SYBRgreen advantage (Takara). 
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RNAseq Library preparation and sequencing was performed through the UCSF Functional 
Genomics Core and aligned to Ensembl Mouse GRCh38.78 (mm10) genome using STAR software 
and analyzed using DESeq2 as previously reported.  Transcripts with at least a mean normalized 
count of 12.3 were used in the analysis, resulting in 12,074 annotated ENSEMBL transcripts.  
Ago2-HITSCLIP library preparation 
Libraries were prepared as previously described(Chi et al., 2009; Gagnon et al., 2019; Loeb 
et al., 2012).  Briefly, 108 activated B cells/ml (5 mice per library) were UV crosslinked 1x 400mJ 
and 2x 200mJ and pelleted.  Ago2 immunoprecipitation with 2D4 (Dako) was performed and 
protein/RNA complexes were digested with RNAse1, 3’ and 5’ adapters were ligated, and cDNA 
created from SSIII. Library was amplified with Phusion taq polymerase (NEB) to the peak 
exponential by qPCR with SYBRgold (Thermo Fisher)  before being purified of adapter dimer on 
a 10% TBE (Bio-Rad) gel and analyzed by a Bioanalyzer micro DNA kit (Agilent).  Libraries were 
combined and sequenced on an Illumina HISEQ-2500.  Reads were binned based on individual 
barcode and aligned to the genome using Bowtie (John Hopkins University).  Annotations were 
made using an in-house aligning algorithm for each library.  Libraries were combined by genotype 
and combined libraries were used to run dCLIP (Wang et al., 2014) with default settings.  All 
regions more bound in flox libraries or Δ libraries were intersected with miR-221/222-3p seed 
sequence reference BED file (generated in house), and those regions were further binned based on 
dCLIP internal score >1 or >10 to increase confidence of true binding regions.   
In vivo house dust mite challenge and Goat anti-IgD serum immunization 
 Mice were primed with 25ug in 50 µl PBS HDM (Stallergenes Greer) by oropharyngeal 
aspiration, and 7 days later the mice were challenged similarly for 5 consecutive days before being 
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bled at D14 for serum analysis.  Mice were immunized i.p. with 300 µl goat anti-IgD serum and 
spleen and inguinal lymph nodes analyzed 7 days later by flow cytometry. Flow cytometry plots 
and analysis are of lymph node samples.    
ELISA 
 Serum was collected by submandibular bleed and micro-centrifugation at >18,000g for 30 
mins.  Half area high-binding 96 well plates (Costar) plates were used for all assays.  For total Ig 
at steady state µplates were coated with Goat anti-Ig (2 µg/ml, Southern Biotech) overnight in 
coating buffer bicarbonate/carbonate coating buffer (100 mM, pH 9.6).  Diluted serum was added 
over night at 4 C or at room temperature for 2 hours, and detected with biotinylated goat anti-IgG1, 
IgG3, IgG2b, or IgM (2 µg/ml, Southern Biotech) followed by HRP-avidin (1:5000, Southern 
Biotech) and developed with Super AquaBlue ELISA Substrate (Thermo Fisher) all with standard 
curves and read out a 405 nm absorbance. For total IgE the process was the same except for plates 
were coated with anti-IgE (2 µg/ml, R35-72) and detected with biotinylated anti-IgE (2µg/ml, R35-
118).  HDM specific IgE ELISA the coating process was the same as total IgE, however instead 
of detection with biotinylated anti-IgE, biotinylated HDM was used at 2 µg/ml followed by avidin-
HRP and TMB substrate stopped with 0.16M sulfuric acid and read at 405 nm.  For HDM specific 
IgG1 plates were coated with HDM (10 µg/ml) overnight and serum overnight at 4C or 2hr room 
temperature and then detected with biotinylated anti-IgG1 followed by avidin-HRP and TMB 
substrate (Thermo Fisher) stopped with 0.16M sulfuric acid M sulfuric acid. 
Flow cytometry  
For in vivo experiments single cell suspensions were prepared from spleen or lymphnode 
by gently passing them through 70 µm nylon mesh filters in complete RPMI.  For Bone marrow, 
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long bones were cut at base and a 26 G needle was used to expel bone marrow, into complete 
RPMI.  Single cell suspension was created by resuspending the BM with an 18 G needle and 
suspension was filtered through a 70 um filter.  Fc receptors were blocked with anti-CD16/CD32 
(2.4G2) and 2% normal rat serum in FACS buffer (PBS + 2% Fetal Bovine Serum + 2 µm EDTA 
+ .01% NaN3) before staining with antibodies for surface markers. Conjugated antibodies used 
included BV605 anti-CD4 (RM4-5), BV605 and PE-Cy7 anti-CD19 (6D5), PerCP-Cy5.5 anti-
CD43 (1B11), AF647 anti-B220 (RA3-6B2), AF488 anti-IgM (RMM-1),  ef450 and PE anti-IgD 
(11-26c), PE and APC anti-IgG1 (A85), biotin anti-IgE (R35-118), unconjugated and PE anti-IgE 
(RME-1), APC anti-CD138 (281-2), PE-Cy7 anti-CD45.2 (104),  PerCP-Cy5.5 anti-CD45.1 
(A20), PacBlue anti-CD21/35 (7E9), PE-Cy7 anti-CD23 (B3B4), PE anti-CD93 (AA4.1), BV711 
anti-CD24 (M1/69).  Biotin conjugates were detected using BV711 Streptavidin (BioLegend). 
Intracellular IgE staining was performed as previously described (Yang et al., 2018; Yang et al., 
2012), where live cells were stained with surface antibody stain + 1:50 purified anti-IgE (RME-1) 
before fixing with BD cytofix/cytoperm and staining intracellularly with PE anti-IgE (RME-1). 
Dead cells were detected using efluor780 fixable viability dyes (Thermo Fisher). Flow cytometry 
analysis was performed on an LSRii cytometer or a FACSAria for sorting (BD). 
Dual luciferase assay 
Dual luciferase constructs were generated, and assay performed as previously reported 
(Gagnon et al., 2019; Pua et al., 2016).  Cells were stimulated and transfect as outlined and 
luciferase activity was measured 24 h after transfection with the Dual Luciferase Reporter Assay 
System (Promega) and a FLUOstar Optima plate-reader (BMG Labtech). At least 1 kb of the 
3’UTR of Cd164, Foxp1 and Arid1a including the putative miR-221/222-3p seed match 
sequence(s) were cloned into the psiCHECK-2 luciferase reporter construct (Promega). Primers 
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used are as follows: Foxp1 for: TAAGCAGCTCGAGAGCATGGTGACAGGGCTAAG; Foxp1 
rev: TGCTTAGGCGGCCGC CTCCCCCGCAAAAGACAAAG; Cd164 for: 
TAAGCAGCTCGAGAGATGCCACACAG GGCAATC; Cd164 rev: 
TGCTTAGGCGGCCGCTGCTTGTGCAGCAAGTATGG; Arid1a for: TAAGCAGCTCGAG 
CCTCAGGACCCCACCCTAT Arid1a rev: TGCTTAGGCGGCCGC 
CACGTGGAACATATAGTATAAAG. 
Software and Statistics 
Data visualization and statistical calculations were performed using Prism GraphPad. 
Statistical tests and p values for each experiment are specified in figure legends for a single 
comparison between two groups, a student’s t-test was used (paired or unpaired where mentioned); 
for multiple comparisons between pre-selected control and all other groups, a one way ANOVA 
with Dunnet’s square test; and for multiple comparisons where all groups were compared, a one 
way ANOVA test with a Tukey correction for multiple comparisons was used. Flow cytometry 
data were analyzed with Flowjo version 10.2. Gene ontology was run using the Metascape analysis 
software (Zhou et al., 2019).  CDF plots were generated using ggplot2, and MA plot was generated 
from DESeq2 results on miRNA captured reads in R version 3.3.4.  Figures made in Adobe 
Illustrator. 
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Results 
Development of a system to systematically interrogate miRNA regulation of class switch 
recombination 
 In prior work, we devised an arrayed screening approach to identify miRNAs that regulate 
helper T cell differentiation and effector function (Pua et al., 2016; Steiner et al., 2011). This 
approach allowed us to isolate the function of individual miRNAs by transfecting each one into T 
cells that lack endogenous miRNAs due to induced genetic deficiency for the miRNA biogenesis 
factor Dgcr8. For this study, we extended this approach to interrogate miRNA function in B cells. 
Dgcr8 can be deleted with high penetrance during late stages of T cell development, but B cells 
exhibit a developmental defect at the pro to pre-B cell transition in the absence of miRNA 
biogenesis machinery (Koralov et al., 2008). To study the role of miRNAs in regulating class 
switch recombination (CSR), we bred C1-cre Dgcr8fl/fl Rosa26-LSL-YFP mice to allow inducible 
Dgcr8 inactivation in B cells upon activation of the Ighg1 germline transcript promoter. Splenic B 
cells from these mice were stimulated with mitogenic anti-CD180 crosslinking antibody and low 
dose IL-4 (1 ng/ml) for 48 hours (Day -2 to 0) to force expression of cre recombinase and inactivate 
Dgcr8 without inducing CSR, then transferred to classical CSR conditions of LPS and high dose 
IL-4 (25 ng/ml) for an additional 48-96 hours (Day 0 to 4) (Fig. 2.1A). Thereafter, we analyzed 
viability, YFP as a reporter cre activity, and surface IgD and IgG1 expression by flow cytometry. 
In these cultures, 95% of viable cells expressed YFP at Day 2, indicating nearly uniform induction 
of cre recombinase activity (Fig. 2.1B, left panel). Importantly, these cells remained capable of 
undergoing CSR (Fig. 2.1B, right panel).  
To validate Dgcr8 ablation, we isolated RNA from C1-cre Rosa26-LSL-YFP B cells that 
were also Dgcr8 fl/fl (D8-KO), Dgcr8fl/+ (D8-HET) or Dgcr8+/+ (D8-WT) to measure Dgcr8 
transcript and mature miRNAs throughout the stimulation timeline. Dgcr8 mRNA abundance was 
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decreased by 8-fold in the D8-KO cells compared to D8-HET and D8-WT cells after the initial 48 
hour stimulation and continued to decrease through day 4 (Fig. 2.1C). Furthermore, the activation-
induced miRNAs mmu-miR-155-5p and mmu-miR-21-5p had 2 to 16-fold decreased expression 
in D8-KO compared to D8-HET and D8-WT cells, consistent with loss of Dgcr8-dependent 
miRNA processing activity (Fig. 2.1C).  In contrast, mmu-miR-484-5p was unaffected throughout 
the stimulation and increased at Day 4 (Fig. S2.1A), consistent with previous reports that Dgcr8-
independent miRNAs increase in abundance in the absence of Dgcr8-dependent miRNA 
biogenesis (Babiarz et al., 2008).  
 Utilizing these stimulation conditions, we tested the role of 85 miRNAs that are  expressed 
in naïve, activated, and/or germinal center B cells (Fowler et al., 2015; Kuchen et al., 2010; Zhang 
et al., 2009). We transfected B cells using the Neon next generation transfection system (Pua et 
al., 2016; Steiner et al., 2011) to introduce individual miRNA mimics into D8-KO activated B 
cells at D0 and measured CSR to IgG1 at D2. These optimized conditions achieved close to 100% 
transfection efficiency with small RNAs, as indicated by uniform down-regulation of CD45 in 
cells transfected with an siRNA against its transcript, Ptprc (Fig. S2.1B). Surface IgG1 expression 
implicated miR-155-5p as a negative regulator of CSR to IgG1 (Fig. 2.1D), consistent with 
previous studies demonstrating that mutation of the miR-155 binding site in the Aicda 3’UTR led 
to an increase in transcript, protein and double stranded break induction in activated B cells 
(Dorsett et al., 2008; Teng et al., 2008). Similarly, congruent with a previous study, miR-18a 
positively regulated CSR (Xu et al., 2015). Interestingly, miR-222-3p was the most potent positive 
regulator of IgG1 surface expression (Fig. 2.1D). This miRNA and its family member miR-221-
3p have been implicated in early B cell development and homing to the bone marrow (Knoll et al., 
2013; Petkau et al., 2018), but not in CSR or B cell activation. In a re-screen of the top 10 and 
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bottom 10 regulating miRNAs and their family members, both miR222-3p and miR-221-3p 
increased CSR compared to control mimic (Fig. S2.1C). Given this consistent and robust effect, 
we decided to further investigate the role of the miR-221/222 family in CSR. 
Germline deletion of the miR-221/222 cluster on the X chromosome does not alter B cell 
development. 
In both mice and humans, miR-221 and miR-222 are processed from a single primary 
miRNA transcribed from the Mirc50 locus on chromosome X. We generated mmu-miR221/222 
deficient mice.  We inserted loxP sites flanking miR-221 and miR-222 by gene targeting to create 
a conditional mutant allele (flox) that can be irreversibly converted to a deleted allele (Δ) upon 
introduction of cre recombinase. B cells from wildtype and flox mice expressed equivalent 
amounts of miR-221-3p and miR-222-3p, and these miRNAs were undetectable in B cells from Δ 
mice generated by cre expression in the germline (data not shown, see also Fig. 2.5C). In all further 
experiments, we compared mice with these two targeted alleles to determine the effect of miR-221 
and miR-222 in B cells. Mice bearing either flox or Δ allele(s) exhibited normal B cell development 
in the bone marrow, with similar numbers and frequencies of pro-B, pre-B, immature and mature 
B cells (Fig. 2.2A-B). There was a subtle decrease in the frequency of transitional B cell subsets 
T2 and T3 in the spleen of Δ mice, but no difference in the numbers of transitional and mature B 
cells in the spleen (Fig. 2.2C-D). The abundance of serum IgM, IgG1, IgG2b and IgG3 were 
unchanged in flox and Δ mice (Fig. 2.2E), while IgE was undetectable in these unimmunized 
animals (data not shown). We conclude that the absence of miR-221 and miR-222 does not grossly 
perturb B cell development in the bone marrow or maturation in the periphery. 
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miR-221/222 regulate CSR to IgG1 and IgE in vitro  
To test whether endogenous miR-221/222 regulate CSR, we compared flox and Δ B cells 
cultured under the same conditions used to screen for functional miRNAs in Dgcr8-deficient B 
cells.  Compared to flox B cells, Δ B cells transfected with a control miRNA mimic (CM) showed 
a two-fold reduction in CSR to IgG1 (Fig. 2.3A, compare grey and black bars labeled CM). 
Transfecting Δ B cells with either miR-221-3p or miR-222-3p mimic restored IgG1 CSR to the 
frequency seen in CM-transfected flox B cells (Fig. 2.3A, compare grey bars). These data indicate 
that the CSR defect in Δ B cells is due to the absence of mature miR-221/222 and demonstrate that 
this defect can be reversed by restoring miRNA expression in mature B cells. Furthermore, miR-
221-3p or miR-222-3p mimic transfection further increased IgG1 CSR in flox B cells (Fig. 2.3A, 
compare black bars), indicating that endogenous miR-221/222 is a dose-limited factor that 
enhances CSR to IgG1. 
To determine the expression profile of these miRNAs, we performed qPCR for miR-221-
3p and miR-222-3p on RNA from B cells stimulated under various conditions known to induce 
CSR to IgG1 and IgE. Compared to naïve B cells, stimulation with LPS + IL-4 for 4 days increased 
expression of miR221-3p and miR-222-3p by 3.7 and 2.5 fold, respectively (Fig. 2.3B). 
Stimulation with anti-CD40 + IL-4 increased miR-221-3p and miR-222-3p expression 8.1 and 3.1 
fold, respectively, and the further addition of IL-21 in these conditions increased miR-221-3p 
induction to 12.5-fold and miR-222-3p to 4.7 fold that of naïve cells (Fig. 2.3B).  Stimulating flox 
and Δ B cells with anti-CD40 + IL-4 + IL-21 revealed a requirement for miR-221/222 for optimal 
CSR to IgG1 and IgE (Fig. 2.3C-D).  The frequency of IgE+ cells was significantly reduced in Δ 
B cells compared to flox B cells in three independent experiments. The frequency of IgG1+ cells 
was consistently reduced in two of these experiments, with the third showing the highest frequency 
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of IgE+ cells. This could be due to depletion of IgG1+ cells by consecutive CSR to IgE (Cameron 
et al., 2003; Mandler et al., 1993; Yoshida et al., 1990), or a higher rate of direct CSR to IgE in 
this experiment. In any case, comparing the combined frequency of IgE+ and IgG1+ cells revealed 
a clear and statistically significant CSR defect in Δ B cells compared to flox B cells (Fig. 2.3D). 
Given that CSR correlates with proliferation capacity (Hodgkin et al., 1996), CTV staining was 
performed on congenically labeled co-cultured Δ and flox cells in anti-CD40 + IL-4 + IL-21 
conditions to determine if there was a proliferation defect in the absence of these miRNAs.  
Interestingly we found that Δ B cells showed a defect in the frequency of cells dividing 6 or more 
times compared to flox (Fig. 2.3E), indicating a subtle proliferation defect.   
miR221-222 regulates IgE production in vivo  
Having confirmed an in vitro CSR defect in the Δ B cells, we went on to test whether the 
defect in CSR would translate to a physiological in vivo model of allergy and asthma, specifically 
house dust mite challenge.  Examining total and HDM specific IgE titers in mice challenged with 
HDM by ELISA, showed that the Δ mice had a statistically significant defect in total IgE 
production, and a trending defect in high affinity HDM specific IgE production (Fig. 2.3F).  No 
difference was seen in in vivo IgG1 production in this model, limiting the in vivo effect of this 
miRNA cluster to IgE production, specifically. 
To determine if the in vivo effect was due to IgE cell number and the plasma cell fate 
decision, we utilized a goat anti-IgD polyclonal B cell activation model (Finkelman et al., 1987).  
Seven days post immunization with goat anti-IgD serum showed a massive B cell response, where 
around half of the total lymph node cells were composed of CD138+, CD19int B cell plasma-blast 
cells (Fig. 2.4A).  While the frequency of total plasma cells was not different between flox and Δ 
animals (Fig. 2.4B), the frequency of IgE+ plasma cells was decreased in Δ animals compared to 
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flox (Fig. 2.4C), as were the numbers of total plasma cells and IgE+ plasma cells (Fig. 2.4D-4E).  
This decrease in frequency and number of IgE producers in the Δ animals is congruent with the 
findings of increased IgE serum levels in HDM challenged flox animals compared to Δ animals 
and provides two independent in vivo systems where IgE production is diminished in the absence 
of miR-221/222-3p. 
Combination of Ago-2-HITS-CLIP and mRNA-seq reveal 70 plausible miR221/222 targets 
Having determined a clear in vitro and in vivo phenotype, of miR-221/222-3p in CSR to 
IgG1 and IgE, we wanted to determine the direct targets of this miRNA family in activated B cells.  
To determine direct targets of miR-221-3p and miR-222-3p we performed Ago-2-HITS-CLIP on 
Δ and flox B cells stimulated for 4 days with anti-CD40 + IL-4 + IL-21.  Libraries were generated 
and sequenced as previously described (Gagnon et al., 2019).  Four independent libraries were 
generated for Δ and flox genotypes.  Analysis of the target transcript space identified the 3’UTR 
as the most abundant RNA species target as would be expected, although binding was seen in 
exon, intron, and 5’UTR space as well (Fig. 2.5A).  Furthermore a 2:1 miRNA: non-miRNA ratio 
of reads was captured from the library, indicating either preferential cross linking of miRNA in 
Ago2-miRNA-targetRNA complexes, or an abundance of AGO2-miRNA complexes not yet 
bound to target RNA sequences in our activated B cells (Fig. 2.5B).   Furthermore analysis of the 
differentially bound miRNAs by DESeq2 analysis showed that both miR-221-3p and miR-222-3p 
(as well as their star sequence 5p counterparts) were differentially captured in flox libraries and 
absent in Δ libraries,  indicating a complete deletion of the miRNAs as well as confirming that 
global miRNA expression and loading into Ago2 is not altered in the absence of this cluster (Fig. 
2.5C).   
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The 4 Ago2-HITSCLIP libraries for each  genotype were combined for a single comparison 
of differential peak binding, utilizing dCLIP (Wang et al., 2014).  Utilizing sequence homology 
identity of all miR-221/222-3p target sites within the mouse genome identified 10,638 possible 
binding sites in the annotated 3’UTRs of the mouse genome. To validate the efficacy in which 
dCLIP positively identified miR-221/222-3p peaks, differential peaks containing at least a 6-mer 
target site were binned, and those more bound in the flox than Δ and vice versa were analyzed at 
increasing differentials determined by the program.  Using the internal dCLIP-differential ranking 
metric of at least 1 yielded a total of 652 peaks in 534 gene transcript 3’UTRs that were more 
bound in the flox than Δ library.  However, using the same parameters of a differential of at least 
1 yielded a total of 636 peaks in 547 gene transcript 3’UTRs that were more bound in the Δ than 
flox library, of which 80 of those transcripts overlapped with those in the flox (Fig. S2.2A).  To 
improve confidence of the truly differential targets and limit the amount of seed sites that were 
more occupied in Δ and flox due to spurious read differences from adjacent miRNA binding, a 
differential of 10 was used, and in this case at least 6-mer containing peaks more bound in the flox 
lead to a total of 412 peaks in 343 gene transcript 3’UTRs.  When the analysis was performed with 
the differential of 10 on sites more bound in Δ libraries compared to flox only 61 peaks were found 
in 57 gene transcript 3’UTRs, and of these only 8 gene transcripts overlapped with those of flox 
(Fig. S2.2B).  
RNA sequencing was performed on flox and Δ B cells stimulated similarly to the Ago-2-
HITSCLIP libraries to determine differentially expressed genes between Δ and flox activated B 
cells.  A total of 12,074 ENSEMBL transcripts were found to be expressed under these conditions, 
of which 429 were differentially expressed by an FDR <0.1.  Of these differentially expressed 
transcripts, 286 were upregulated in the KO compared to the flox libraries.  The 12,074 transcripts 
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were binned into subsets containing no miR-221/222-3p seed match, only 6mer match, at least 
7mer match (+ 6mer ), or at least 8mer match (+ 7mer + 6mer) binding sites in annotated 3’UTRs.  
Cumulative distribution function (CDF) plots were generated and each seed-containing bin was 
compared to the no seed bin generating a Differential D= 0.132 for 6-mer, D= 0.126 for 7mer, and 
D= 0.171 for 8-mer, indicating increased differential expression of 8-mer seed match containing 
transcripts in the Δ compared to flox B cells (Fig. 2.6A).  The absence of miR221/222 leads to a 
subtle increase in expression of all genes containing a putative seed sequence by sequence match 
alone.  Using these 343 dCLIP putative target genes to create a CDF plot compared to all other 
expressed genes led to a differential of D= 0.19 (Fig. 2.6B).  Indicating an increased confidence 
of these genes being direct targets and providing more confidence of direct targeted regulation by 
miR-221/222-3p than that of putative seed sequence match alone. 
To compare our dCLIP analysis with predicted targets from the sequence homology, we 
analyzed the predicted target genes from the Bartel lab’s Targetscan 7.1 program (Agarwal et al., 
2015).  Targetscan 7.1 predicts 404 gene targets for the miR-221/222-3p family, of which 290 
were expressed in our B cell cultures by RNA-seq.  Generating CDF plots of the 290 Targetscan 
predicted genes compared to all others produced a differential D=0.193 (Fig. 2.6C), further 
increasing the confidence of these genes being directly targeted by miR-221/222-3p.  Of these 290 
Targetscan predicted gene targets, 70 of them overlapped with those 343 gene targets predicted 
from our differential HITS-CLIP analysis (Fig. S2.2C).  Creating a further CDF plot comparing 
these 70 putative targets to all other genes further increased the differential D=0.293, providing 
strong confidence for these genes being directly regulated by this miRNA family (Fig. 2.6D).  The 
union of both cell specific dCLIP and the predictive capabilities of Targetscan7.1 provided a subset 
of genes we could directly test through small inhibitory RNA screening.  Running Metascape 
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(Zhou et al., 2019)  on the 70 genes, provided a gene ontology profile enriched in a cell cycle 
profile, among others (Fig. 2.6E), congruent with our finding of this miRNA regulating 
proliferation in mature B cells, and findings in other cell types (Galardi et al., 2007; Mayoral et 
al., 2009). 
siRNA screen of the 70 direct gene targets implicates Foxp1, cd164 and Arid1a as regulators of 
CSR to IgG1/IgE. 
 To validate the putative targets as regulators of CSR, we performed and siRNA screen 
similar to that of the miRNA screen performed in Fig. 2.1.  In this case B6 mice were used with 
the same timing schematic as the miRNA screen, where cells were first activated in anti-CD180 + 
IL4 low dose conditions and then transferred to canonical CSR conditions of LPS + IL4 high dose 
conditions.  Four siRNAs were used per gene target, and surface IgG1+ and viability were analyzed 
by flow cytometry.  Of the 85 targets, siRNA KD of the pro-apoptotic factor Bcl2l11 (Bim protein) 
increased viability of transfected cells to 65%, a 15% increase from control siRNA (Fig. 2.7A).  
Furthermore, siRNA KD of Rnps1, an enzyme necessary for pre-mRNA splice junction formation 
(Mayeda et al., 1999), negatively regulated both CSR to IgG1 as well as viability.  SiRNA KD of 
three candidate miR-221/222 targets: Foxp1, Cd164, and Arid1a - resulted in the highest increase 
of surface IgG1 frequency compared to control mimics (Fig. 2.7A).  This KD correlated increase 
of surface IgG1 was confirmed in an siRNA rescreen where these were the three most positive 
regulators of CSR to IgG1 (Fig. 2.7B).  Analysis of our RNA sequencing found that expression of 
Foxp1and Arid1a were statistically higher in Δ mice compared to flox mice (1.45 and 1.40 fold 
increased, respectively), whereas Cd164 expression was only moderately different between the 
two genotypes at 1.06 fold higher in Δ vs flox mice (Fig. 2.7C).  Furthermore, dual luciferase 
constructs were made to confirm that these transcripts’ 3’UTRs were targeted directly by 
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miR221/222.  We found that both Cd164 and Foxp1 3’UTR fragments containing the Targetscan 
7.1 predicted sites (as well as an additional 6-mer sequence in the 3’UTR of Foxp1) showed 
destabilization and direct targeting of that 3’UTR.  This in conjunction with the differential binding 
implicated from our dCLIP expression supports that Cd164 and Foxp1 are direct gene targets, 
whereas Arid1a may be an indirect target of this miRNA cluster. 
Genetic Ablation of Foxp1 increases B cell propensity to Switch to IgG1 and IgE 
To confirm that Foxp1 is itself a regulator of CSR to IgG1 and IgE, we utilized a tamoxifen 
inducible cre deletion model of Foxp1 and then cultured the cells under IgG1/IgE class switching 
conditions (Fig. 2.8A).  CreERT2 mediated Foxp1fl/fl deletion (Foxp1-KO) B cells cultured on 
BAFF/CD40L expressing cells in the presence of IL4 showed a threefold increase in the frequency 
of IgG1 and IgE surface expression compared to Foxp1fl/fl or CreERT2  (Foxp1-WT) cells (Fig. 
2.8B).  Induction of CSR to IgG1 ranged from 10% to 60% from experiment to experiment, while 
that of IgE ranged from 3% to 20%, however the 2.5-3 fold further induction of either isotype in 
Foxp1-cKO compared to WT cells was robust.  Interestingly the CSR to both IgE and IgG1 
required IL-4 indicating that the activated B cells were not switching during deletion of pre-
immunized mice in the in vivo setting.  This confirmation of the siRNA KD, implicates miR-
221/222 mediated Foxp1 regulation as a modulator that controls CSR to IgG1 and IgE in B cells.  
Genetic Ablation and Chemical inhibition of Arid1a affects IgG1 and IgE CSR. 
 We utilized another genetic approach to target Arid1a deletion in mature mice by utilizing 
CD21cre (Cre+WT) and Arid1afl/wt (Arid1a-WT) mice to make heterozygous animals CD21cre 
Arid1afl/wt (Arid1a-HET).  Deletion of Arid1a in the hematopoietic system causes profound defects 
in development (Han et al., 2019). Using the same in vitro stimulation conditions of anti-CD40, 
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IL-4, IL-21 we found that Arid1a-HET mice showed a defect in the frequency of IgE CSR 
compared to Cre+WT and Arid1a-WT control mice (Fig. 2.9A right panel), and this was 
concordant with an increase in the frequency of IgG1+ B cells (Fig. 2.9A, left panel).  Indicating 
that partial loss of this BAF complex member alters CSR fate in these conditions.   
 We also used a specific Arid1a-BAF complex chemical inhibitor, BRD-K80443127 a 
macrolactam (Marian et al., 2018), to test the effect of BAF complex dysregulation on CSR to 
IgG1/IgE.  Interestingly, cells cultured in anti-CD40, IL-4, IL-21 conditions showed no decrease 
in viability in the presence of BRK-K8-4431327 (Fig. 2.9B top left panel), and even a slight 
increase at the 20-40 uM range, indicating that dysregulation of these complexes is not vital for 
mature B cell homeostasis under this stimulus.  Similarly, plasma cell differentiation showed a 
defect only at the highest concentration of 40 uM (Fig. 2.9B top right panel), while both IgG1 and 
IgE showed a dose dependent decrease (Fig. 2.9B bottom left and bottom right, respectively).  
Interestingly, the frequency of IgE switching was more sensitive to Arid1a-BAF inhibition 
beginning at 5 uM compared to IgG1 at 10uM.  Furthermore IgG1 frequency remained 80% of 
vehicle control up to 40uM inhibitor concentration, thereafter falling off sharply to 10%.  Targeting 
Arid1a through both genetic and chemical means shows that this miR-221/222-3p regulated gene 
has a direct effect in modulating CSR to IgG1 and IgE.   
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Discussion 
MicroRNA rescue screens have been used to study embryonic stem cell pluripotency and 
self-renewal (Froidure et al., 2016; Wang et al., 2008), and in miRNA-depleted lymphocytes to 
study T cell proliferation, differentiation and cytokine production (Pua et al., 2016; Steiner et al., 
2011). In this study, we developed and executed a rescue screen in primary mouse B cells to reveal 
that miR-221/222 can positively regulate CSR to IgG1, and leveraged this finding to elucidate a 
previously unknown miRNA regulated gene network that modulates CSR to IgG1 and IgE. These 
rescue screens measure the effects of individual miRNAs introduced at potentially 
supraphysiological quantities in the absence of other miRNAs. However, analysis of miR-221/222-
deficient B cells demonstrated that endogenous miR-221/222 regulate CSR in vitro and in vivo. 
Extending this screen for miRNA influence with biochemical elucidation of direct targets of miR-
221/222, we uncovered evidence for a network of downstream regulators of CSR including Foxp1 
Arid1a, and Cd164.  
Foxp1 is essential for B cell development (Hu et al., 2006) and its down regulation in 
activated mature B cells is necessary for germinal center entry and plasma cell differentiation 
(Sagardoy et al., 2013; van Keimpema et al., 2015).  Through the investigation of miR-221/222 
targets, we uncovered an additional role for this transcription factor as a negative regulator of CSR 
to IgG1 and IgE.  Foxp1 deletion in mature B cells also hinders T-independent B cell response, 
production of IgG3, and B1 cell development (Patzelt et al., 2018).  A previous study of T-
dependent antibody responses showed no clear difference in IgG1 serum titers in B cell lineage-
specific Foxp1-deficient mice, but this finding is complicated by developmental defects that result 
in fewer mature B cells in these mice (Dekker et al., 2019; Patzelt et al., 2018).  As previously 
reported (Dekker et al., 2019), B cells lacking FOXP1 exhibited increased proliferation in response 
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to CD40 and IL4 stimulation. This accelerated cycling likely contributes to their dramatically 
increased CSR to IgG1 and IgE in vitro. However, whether FOXP1 acts as a transcriptional 
repressor to dampen activation signals, cell cycle regulators or other factors remains to be 
determined. Further studies are needed to fully elucidate the transcriptional targets and 
downstream mechanisms through which FOXP1 controls CSR in conjunction with its effects on 
B cell fate decisions.   
The role of chromatin architecture and remodeling in the context of CSR has recently come 
into full appreciation as DNA orientation and chromatin regulation were shown to be critical for 
switch site orientation and stabilization for AID-mediated mutation (Yu and Lieber, 2019; Zhang 
et al., 2019). Interestingly, our analysis of regulated miR-221/222 interactors identified 3 predicted 
targets that play a role in chromatin remodeling: Ctcf, Smarca5, and Arid1a. CTCF is a central 
regulator of chromatin domain architecture and CSR (Perez-Garcia et al., 2017; Thomas-
Claudepierre et al., 2013; Zhang et al., 2019). Human Ctcf is an established target of miR-221/222 
(Lupini et al., 2013). Arid1a encodes a key component of the BAF nucleosome remodeling 
complexes, which are critical for chromatin remodeling during hematopoiesis (Han et al., 2019). 
We found that the action of these complexes is necessary for B cell activation as cells cultured 
with an ARID1A-containing BAF complex inhibitor (Marian et al., 2018) remained in a quiescent 
state, neither undergoing cell death nor proliferation.  However, genetically or pharmacologically 
limiting (rather than eliminating) ARID1A-containing BAF complexes revealed a selective effect 
on CSR. Surprisingly, B cells with reduced ARID1A were more prone to IgG1 CSR but exhibited 
a strong defect in IgE CSR. Whether ARID1A-BAF complex nucleosome remodeling mediates 
access to critical regions of the Igh locus deserves further study. In any case, the selective 
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sensitivity of IgE CSR to BAF inhibition indicates the existence of isotype specific effects of 
regulating (or dysregulating) this machinery. 
Previous studies of miR-221/222 in other immune cell types and cancer demonstrated 
direct regulation of Cdkn1b, which encodes p27-kip protein, a positive regulator of cell cycle 
progression from G1 to S (Fornari et al., 2008; Galardi et al., 2007; Mayoral et al., 2009). Our 
biochemical data also implicated Cdkn1b as a direct target. However, siRNAs against this gene 
decreased B cell proliferation without a discernible effect on CSR. While our data do not 
definitively prove that miR-221/222  directly target Cdkn1b in B cells, the fact that miR-221/222-
deficient B cells exhibited a subtle proliferative defect implicates these miRNAs in regulation of 
B cell cycle progression, possibly through multiple targets including Cdkn1b.   
miR-221/222 appears to regulate allergic responses through coordinate control of multiple 
cell types. Mast cells, basophils, and other granulocytes very strongly express miR-221/222 
(Kuchen et al., 2010; Monticelli et al., 2005), and these miRNAs regulate mast cell proliferation 
and degranulation in response to IgE receptor crosslinking (Mayoral et al., 2011; Mayoral et al., 
2009). In this study, we found that miR-221/222-deficiency also impaired B cell production of IgE 
in allergic airway sensitization and pan-B cell activation models.  Further studies will be necessary 
to determine whether miR-221/222 absence in granulocyte populations further affects allergic 
responses in vivo. The control of complex immunological processes through regulation of distinct 
cell types by a common factor is an interesting regulatory phenomenon exemplified by the 
orchestration of humoral responses by the transcription factor BCL6 (Crotty, 2019; Okada et al., 
2012) and the miRNA cluster miR-17~92 (Baumjohann et al., 2013; Jin et al., 2013; Kang et al., 
2013) acting in both GC B cells and T follicular helper cells.  
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Other highly expressed miRNAs also regulate humoral immune responses, including miR-
155 and miR181b, both of which directly target the critical CSR factor Aicda in B cells (Dorsett 
et al., 2008; Rodriguez et al., 2007; Teng et al., 2008; Thai et al., 2007; Vigorito et al., 2007) (de 
Yebenes et al., 2008). miRNA expression is dramatically modulated in activated B cells (Fowler 
et al., 2015; Kuchen et al., 2010). In our experiments, miR-221/222 were upregulated upon B cell 
activation, yet their abundance was still less than 1% that of the most highly expressed miRNAs.  
Nevertheless, comparing Ago2 binding, gene expression in the presence and absence of miR-
221/222 singled out direct targets even for these modestly expressed miRNAs. We provide these 
data as a resource for mining the Ago2-bound transcript space in mouse B cells activated to mimic 
T cell-dependent stimulation, complementing previous experiments performed under different 
conditions (Hsin et al., 2018; Jin et al., 2013).   
Unbiased investigation of miR-221/222 target genes identified by Ago2-HITS-CLIP and 
gene expression analysis revealed a functionally relevant downstream gene network actively 
regulated in B cells undergoing CSR. Our overall experimental approach, which we term miRNA-
directed target pathway discovery, coopts the coevolution of miRNAs and their targets to reveal 
novel players in biological processes without requiring genome-wide functional screens. miRNA-
directed pathway discovery can be adapted to interrogate cell-type specific miRNA and target 
networks operative in nearly any biological process.  
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Figure 2.1: Development of miRNA rescue screen in mature B cells stimulated to CSR to IgG1 
implicates miR-222 as a regulator.  
A. Timing and stimulation conditions to induce Cγ1-cre deletion of Dgcr8 and transfect miRNA and test 
CSR.  B. Representative flow plot of gating strategy for YFP reporter and IgG1 surface expression. C. RT-
qPCR of D8-WT, D8-HET, D8-KO B Dgcr8 and miRNA expression throughout culturing (Dgcr8 
normalized to Gapdh, miRNAs normalized to snoRNA U6). D. Screen results from the individual miRNA 
rescue transfections at timepoint D2.  Control bar is average of 6 transfections ranging from +1 to -1 z score 
averaged. 
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Figure 2.2: Loss of miR-221/222 does not alter B cell development in the bone marrow nor spleen and 
steady state serum antibody levels are unaffected.  
A.  Representative flow cytometry gating strategy for bone marrow analysis.  Upper left gate is a subgate 
of live, singlet, CD19+, B220+ cells.  Further sub-setting by B220int, CD43+,CD24+, IgM- pro-B cells; 
B220-int, CD43-int,CD24+, IgM- pre-B cells; B220-int, CD24+, IgM-hi, IgD- immature B cells; and B220-
hi, IgM-int, IgD+, CD24-lo mature cells. B. Enumeration of percentage and number of each developmental 
bone marrow subset determined in A.  C.  Representative flow cytometry gating strategy for splenic 
analysis.  Leftmost plot is pre gated on live, singlet, B220+, CD4- cells that are subdivided into transitional 
CD93+ subsets: CD23-, IgM-hi T1; CD23+, IgM-hi T2; and CD23+, IgM-lo T3.  Or subset into mature 
CD93-: CD23+, CD21-int Follicular and CD23 lo, CD21-hi Marginal zone B cells.  D.  Enumeration of 
percentage and number of each developmental splenic subset determined in C.  E  Steady state serum 
concentrations for the labeled isotypes in flox and Δ mice.  All p values from two-tailed student’s t-test 
p>.05 for all unlabeled comparisons *= p<0.05.   
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Figure 2.3: Loss of miR-221/222 leads to defects in B cell CSR to IgG1/IgE in vitro and IgE production 
in vivo.  
A.  Δ or flox B cells stimulated in screen conditions and transfected with miR-221-3p (miR221) or miR-
222-3p (miR222), or control mimic (CM) at D0 and surface IgG1 read out at D2.  3 mice per genotype 
paired student’s t test comparisons within genotype.    Experiment is representative of 3 independent 
experiments. B. Expression of each miRNA in given IgG1/IgE CSR stimulation media for 96 hrs, relative 
to U6 snoRNA.  C. Representative flow cytometry plots CSR phenotype of Δ or flox B cells stimulated in 
anti-CD40, IL4, IL21 media for 96 hours gated on live singlets to determine IgDlo, IgG1+ cells.  IgE+ cells 
are IgM- and gated from IgDlo, IgG1- population D. Quantification of % surface IgE+, IgG1+, or either + 
from figure C.  Combined 3 independent experiments with at least 3 mice per genotype. E.  Quantification 
of Division number from co-cultured Δ and flox B cells stimulated in anti-CD40, IL-4, IL-21 media for 96 
hours.  Paired t test for each co-cultured well.  Combined from 3 independent experiments with at least 2 
independent co-cultures per experiment. F. ELISA data for total IgE and HDM specific IgE in mouse 
challenged with HDM for a 2 week protocol (see materials and methods from 4 independent experiments 
with 4 mice per group.  *= p<0.05; **=p<0.01; ***= p<0.001. 
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Figure 2.4: Loss of miR-221/222 decreases the number of PCs and IgE+ PCs in a pan-B cell activation 
model of Goat anti-IgD immunization.  
A. Representative flow plot of the lymph node cell environment showing PC CD19 int, CD138+ cells gated 
on intra-cellular IgE+ fraction.  B. Frequency and D. Numbers of PC of total lymph node cells.  C.  
Frequency and D. numbers of IgE+ PCs. Each data point represents a mouse from 2 independent 
experiments.  All statistics are from two-sided student’s t-test. * p< 0.05.  
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Figure 2.5: Characterization of Ago-2 binding in Δ or flox B cells stimulated with anti-CD40, IL-4, 
IL-21.  
A. Annotations and relative coverage of reads from each of the Δ and flox B cell libraries aligning to 
annotated mRNA sequences (left) and non-coding RNA sequences (right).  B. Distribution of miRNA and 
non-miRNA reads in each library.  C. Mean Analysis plot for miRNA reads only. Mean miRNA read count 
vs log10 miRNA read count per million of flox vs Δ reads.  Red dots are Differentially captured miRNAs 
by DESeq2 with FDR< 0.05. 
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Figure 2.6: Intersection of dCLIP, RNA-seq, and Targetscan indicate 70 possible gene targets of miR-
221/222 in B cells.  
A-D. CDF plots comparing RNA-seq gene expression on x axis vs cumulative distribution on y axis A. 
genes with at least one 6-mer (green), at least one 7-mer (orange), or at least one 8-mer (red) to those lacking 
a miR-221/222-3p seed site (black). B. dCLIP predicted genes (red) to all others (black). C. Targetscan 
predicted genes (red) to all others (black).  D.  dCLIP and Targetscan predicted genes (red) to all others 
black. E.  Ranked GO terms and kegg pathways enriched in the dCLIP and Targetscan gene subset. 
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Figure 2.7: SiRNA knockdown screen on dCLIP and Targetscan predicted miR-221/222-3p gene 
targets identifies Foxp1, Arid1a, and CD164 as regulators of CSR. 
A. Frequency of Viable vs frequency of surface IgG1+ for the 70 gene targets predicted by dCLIP and 
Targetscan. B.  Z-score plot for surface IgG1 for a rescreen of the top ten and bottom 10 genes from A. C. 
Gene expression data for Foxp1, Arid1a, and Cd164 from RNA-seq data. D. Dual-luciferase reporter assay 
results for B cells transfected with either CM or miR221/222-3p mimic and labeled psicheck-2 constructs 
containing >1kb of each annotated 3’UTR containing miR-221/222 target sequence. *= p<0.05; **=p<0.01; 
****= p<0.0001 
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Figure 2.8:  Genetic ablation of Foxp1 increases the propensity for activated B cells to switch to IgG1 
and IgE. 
A. Schematic for tamoxifen induced deletion and culturing of Foxp1-wt and Foxp1-KO B cells. B. 
Representative flow cytometry plots of B cells from Foxp1-wt and Foxp1-KO mice post stimulation with 
and without supplemental IL-4.  C.  Normalized frequency of IgG1 and IgE surface expression.  Each data 
point represents an individual biological replicate normalized to mean WT Ig frequency (og 1) within each 
experiment.  Statistics generated by two-tailed student’s t-test.*** p<0.001 
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Figure 2.9: Genetic ablation of Arid1a and chemical inhibition of Arid1a-BAF complexes alters B cell 
IgG1 and IgE CSR frequency. 
A.  Quantification of Arid1a-WT, Arid1a-HET, and Cre+WT B cells stimulated with anti-CD40, IL-4, IL-
21 frequency to switch to IgG1 and IgE each point is a single mouse, representative of 2 independent 
experiments.  B.  Quantification of viability, frequency plasma cell (CD138+, CD19int) and frequency of 
IgG1 or IgE surface expression throughout dilution series of chemical lactam. Statistics generated by 
ordinary one-way ANOVA with for A. Dunnet’s multiple comparison test for B all comparisons to vehicle 
alone leftmost column. ** p<0.01, *** p<0.001 ****p<0.0001 
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Supplemental Figure 2.1: Extended Validation of model, transfection method, and miRNA 
candidates 
A.  qPCR timecourse for miR-484-5p a DGCR8 independent miRNA. B. Flow cytometry 
histograms and quantification of CD45 expression on B cells stimulated in conditions outlined in 
Fig. 2.1A, and transfected with CD45 siRNA or Control siRNA C. Follow-up re-screen of top 10 and 
bottom 10 z-score miRNAs from original screen, transfected in duplicate over two replicates plotted on 
individual axes.  
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Supplemental Figure 2.2: Validation scheme for dCLIP analysis cutoff and selection of 
targets based on intersection of dCLIP and Targetscan.  
A/B. Total number of genes containing a miR221/222 seed sequence (6-mer or better) in a region 
with more binding for flox library (aqua) or Δ library (red) or genes having a region for both 
genotypes (white) when filtering on a dCLIP internal parameter of A. 1.  B. 10. C  Of the 343 
genes from B (aqua + white), those that intersect with the 290 genes predicted to be miR221/222-
3p targets by Targetscan (yellow) were selected as siRNA screen candidates (white). 
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Chapter 3: Antigen Complexed with a TLR9 Agonist Bolsters c-Myc and mTORC1 Activity 
in Germinal Center B Lymphocytes 
 
 
 
 
 
 
 
This chapter is adapted from the published work (Wigton et al., 2019):  
Wigton, E. J., et al. (2019). "Antigen Complexed with a TLR9 Agonist Bolsters c-Myc and 
mTORC1 Activity in Germinal Center B Lymphocytes." Immunohorizons 3(8): 389-401. 
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Abstract 
The Germinal Center (GC) is the anatomical site where humoral immunity evolves. B cells 
undergo cycles of proliferation and selection to produce high affinity antibodies against antigen. 
Direct linkage of a TLR9 agonist (CpG) to a T-dependent antigen increases the number of GC B 
cells. We used a T-dependent antigen complexed with CpG and a genetic model for ablating the 
TLR9 signaling adaptor molecule MyD88 specifically in B cells (B-MyD88- mice) together with 
transcriptomics to determine how this innate pathway positively regulates the GC. GC B cells from 
complex antigen immunized B-MyD88- mice were defective in inducing gene expression 
signatures downstream of c-Myc and mTORC1. In agreement with the latter gene signature, 
ribosomal protein S6 phosphorylation was increased in GC B cells from wild type mice compared 
to B-MyD88- mice. However, GC B cell expression of a c-Myc protein reporter was enhanced by 
CpG attached to antigen in both WT and B-MyD88- mice, indicating a B cell-extrinsic effect on 
c-Myc protein expression combined with a B cell-intrinsic enhancement of gene expression 
downstream of c-Myc. Both mTORC1 activity and c-Myc are directly induced by T cell help, 
indicating that TLR9 signaling in GC B cells either enhances their access to T cell help or directly 
influences these pathways to further enhance the effect of T cell help. Taken together, these 
findings indicate that TLR9 signaling in the GC could provide a surrogate pro-survival stimulus, 
“TLR help”, thus lowering the threshold for selection and increasing the magnitude of the GC 
response.   
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Introduction 
Toll like receptors (TLRs) recognize pathogen associated molecular patterns (PAMPs) and 
serve as key mediators of the innate immune response against pathogens. However, TLRs are 
expressed on both adaptive and innate immune cells. Deficiency in these receptors or their key 
signaling molecules, such as MyD88, impair both innate and adaptive responses to pathogens 
(Akira and Takeda, 2004; Blasius and Beutler, 2010; Iwasaki and Medzhitov, 2004). The dual 
function of TLRs in initiating the early inflammatory response while at the same time directly 
shaping the slower antigen-specific adaptive response shows that these receptors act through 
multiple elements within the immune system. It has been appreciated for a number of years that 
several TLRs are expressed by B cells and these receptors regulate B cell activation and fate 
decisions (Gavin et al., 2006; Pasare and Medzhitov, 2005). Studies using mice in which the 
critical TLR-signaling component MyD88 is selectively ablated in B cells or mixed bone marrow 
chimeras in which B cells were selectively deficient in a particular TLR revealed that such mice 
also have substantial defects in germinal center (GC) and plasma cell (PC) generation, and in 
isotype switched antibody titers in response to multiple TLR agonists mixed with T-dependent and 
T-independent antigens (Eckl-Dorna and Batista, 2009; Hou et al., 2011; Jegerlehner et al., 2007).  
This biological role for TLR signaling in B cells is important for making high quality 
antibodies to a number of viral infections of mice, in which case endosomal TLR7 and TLR9, 
which recognize nucleic acids, are critical. (Clingan and Matloubian, 2013; Eckl-Dorna and 
Batista, 2009). BCR-mediated endocytosis of the antigen and associated BCR signaling delivers 
TLR ligands to the endosomal location of these receptors (Chaturvedi et al., 2008; O'Neill et al., 
2009). In addition, TLR7 and TLR9 function in B cells is required for production of anti-DNA and 
anti-ribonucleoprotein autoantibodies in several mouse models of systemic lupus erythematosus 
(Rawlings et al., 2017).  
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One experimental strategy for studying how BCR signaling and TLR9 signaling enhance 
the germinal center response is to immunize with a T-dependent antigen physically coupled to a 
synthetic TLR9 agonist - CpG deoxyoligonucleotides (CpG) (Rookhuizen and DeFranco, 2014). 
In order to activate the potential of TLR9 to enhance a GC response, the antigen must be 
oligovalent (as is the case for a haptenated protein) (Rookhuizen and DeFranco, 2014). The TLR9 
ligand can be present in virus-like particles (VLPs) (Hou et al., 2011; Tian et al., 2018), or 
combined with DOTAP adjuvants (Akkaya et al., 2017) to form liposome-like oligovalent 
antigens. MyD88-deficiency in B cells compromises GC B cell number and antibody titers to such 
antigens (Hou et al., 2011; Rookhuizen and DeFranco, 2014), but how TLR signaling enhances 
the response that remains dependent upon T follicular helper (Tfh) cells is unclear. In a murine 
model of autoimmune lupus in which TLR7 and TLR9 are necessary for sustained autoreactive B 
cell responses, cognate autoreactive T-cells could partially rescue GC B cell activation defects in 
the absence of TLR7/9 (Giles et al., 2017). This suggests the overlap of pro-survival signals 
derived from T cell help and TLR7/9 signaling in supporting GC B cell survival and humoral 
immunity, but the molecular nature of the signals provided by TLRs were not defined. 
Here, we explored the mechanistic basis by which a TLR9 ligand attached to an antigen 
signals within the antigen-specific B cell to promote the GC response. The wildtype GC B cells 
immunized with NP-haptenated T-dependent antigen complexed with a CpG oligonucleotide had 
increased oxidative phosphorylation, mTORC1, and c-Myc gene expression signatures compared 
to MyD88-deficient GC B cells. Remarkably, both c-Myc and mTORC1 are induced by Tfh cell 
mediated interactions with GC B cells through CD40L:CD40 signaling (Calado et al., 2012; 
Dominguez-Sola et al., 2012; Ersching et al., 2017). As such, MyD88-dependent TLR9 signaling 
induced gene expression signatures that were previously associated with Tfh cell help, suggesting 
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that TLR signaling in GC B cells enhanced the GC response by mimicking the effects of Tfh on 
the B cells, without replacing the requirement for Tfh. Together, these findings indicate that TLR9 
signaling in GC B cells can provide a supplemental stimulus that allows more B cells to occupy 
the GC in an environment where Tfh cell help is limiting for survival.  
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Materials and Methods 
Generation of Complex antigens and BCR stimulants 
NP-CGG Complex antigen was generated similarly to as previously published with the 
following modifications: NP(14-30)CGG (Biosearch) was biotinylated using biotin(xx)-NHSS in 
DMF, as previously reported (Rookhuizen and DeFranco, 2014). The biotinylated NP(14-30)CGG 
was mixed (5mg/ml) with streptavidin (Thermofisher) (10mg/ml), and 5’biotinylated CpG oligo 
1826 (CCATGACGTTCCTGACGTT) (IDT) or a 5’biotinylated Non-CpG oligo 
(TCCAGGACTTCTCTCAGGTT) (IDT) (5mg/ml), at a molar ratio of 1:4:48 in PBS, respectively 
for 24 hrs before being washed in 5mls PBS in an Amicon Ultra-15 Centrifugal Filter Unit 10kD 
(Millipore) 3 times, and resuspended at 100µgtotal mass per 50 µl. Similarly biotinylated αIgM 
(goat polyclonal, Jackson Immunoresearch) was mixed with Streptavidin and 5’biotinylated CpG 
oligo 1826 (IDT) or a 5’biotinylated Non-CpG oligo (5mg/ml), at a molar ratio of 2:1:2 in PBS 
for 24hours before being transferred to an Amicon Ultra-15 Centrifugal Filter Unit 10kD filter 
(Millipore) and washed 3 times with PBS and re-suspended at 1.5µg αIgM per µl.  
Mice and Immunizations 
 Mice used in these experiments consisted of Mb1-cre (C(Cg)- Cd79atm1(cre)Reth/EhobJ), 
MyD88 flox (B6.129P2(SJL)-MyD88tm1Defr/J), c-Myc-GFP reporter (B6;129-Myctm1Slek/J) 
(backcrossed 10 times to B6/J) and Eµ-Bcl2 transgenic (C.Cg-Tg(BCL2)22Wehi/J) (a gift from 
the Cyster laboratory) all of which were maintained in house according to all IACUC guidelines. 
Mice were immunized subcutaneously in the scruff and flanks with a total of 100µg NP-CGG in 
complex antigen for cell sorting and in vivo phosphor-flow experiments, and with 25µg NP-CGG 
complex antigen in the footpad for c-Myc-GFP and general flow cytometry experiments. Draining 
 
 
76 
 
lymph nodes were analyzed. Eµ-BCL2 transgenic c-Myc-GFP mice were immunized with 100µg 
NP(14-30)-CGG (Biosearch) in alum Imject (ThermoFisher) intraperitoneally, and GC B cells 
were isolated from spleen 12-14 days later. 
RNA isolation and mRNA-sequencing 
10,000 NP+ GC B cells were collected by FACS sorting directly into the lysis buffer of the 
Dynabead direct mRNA extraction kit (Thermo Fisher). mRNA was isolated by use of poly-dT 
beads according to the manufacturer’s instructions (Thermo Fisher). Library preparation and RNA 
sequencing was performed through the UCSF Functional Genomics Core and aligned to Ensembl 
Mouse GRCh38.78 (mm10) genome using STAR software and analyzed using DESeq2 as 
previously reported(Pua et al., 2016).  
Flow cytometry,  
Single cell suspensions were prepared from either popliteal or inguinal, axillary, and 
brachial LNs by gently passing them through 70µm nylon mesh filters. Cells were collected by 
centrifugation and incubated with anit-CD16/CD32 (2.4G2) in FACS buffer (PBS + 2% Fetal 
Bovine Serum + 2 µm EDTA + .01% NaN3) to block antibody binding to Fc receptors before 
staining with antibodies for surface markers. For phospho-flow analysis of in vivo cells, mice were 
perfused with 10% Paraformaldehyde (PFA) directly after sacrifice (Sigma), and single cell 
suspensions from Lymph nodes were prepared directly in 2% PFA and incubated for 15 minutes 
on ice before permeabilizing the cell plasma membranes with ice cold methanol. Fixed cells were 
rehydrated with PBS, washed by centrifugation in FACS buffer and blocked and stained with 
antibodies as described above. Conjugated antibodies used included PE-Cy7 anti-CD95 (Jo2); 
FITC and PerCP-Cy5.5 anti-GL7, BV605 anti-CD19 (6D5), FITC anti-B220 (RA3-6B2), biotin 
 
 
77 
 
anti-CD11c, biotin anti-CD3ε (145-2C11), biotin anti-Ter119, biotin anti-Gr1, ef450 anti-IgD (11-
26c), biotin anti-CXCR4 (2B11), APC anti-CD86 (GL-1), APC anti-CD83 (Michel-19), AF647 
anti-pS6 ser240/244 (D68F8), AF647 anti-pS6-ser235/236 (D57.2.2E), AF647 anti-pAkt ser473 
(D9E). Biotin conjugates were detected using BV711 or BV786 Streptavidin (BioLegend). NP(8-
30)-PE (Biosearch) was used to detect NP-binding B cells. Dead cells were detected using 
efluor780 or UV Blue fixable viability dyes (Thermofisher). Flow cytometry analysis and sorting 
was performed on an LSR II and a FACS Aria II cytometers (BD), respectively.  
In-vitro and Ex vivo naïve and GC B cell isolation and stimulation 
WT, B-MyD88-, WT-c-Myc-GFP and B-MYD88-c-Myc-GFP naive B cells were isolated 
using Dynabead negative CD43 selection kit (ThermoFisher) and stimulated in RPMI 1640 
supplemented with 10% FCS, HEPES, 2-mercaptoethanol, and L-glutamine with αIgM-CpG and 
αIgM-Non for 24 hours then stained for viability before being analyzed by flow cytometry or fixed 
before staining for phospho-flow. Eµ-BCL2 MycGFP B cells were isolated by anti-CD11c, anti-
CD43 and anti-IgD (GC) or anti-GL7 (naïve) biotin antibodies followed by an anti-biotin magnetic 
bead isolation (Miltenyi) according to a previously published protocol (Cato et al., 2011). Purity 
was confirmed at least 95% B220+ for naïve B cells and 90% Fas+, CD38- for GC B cells. Cells 
were stimulated with 10-20 µg αCD40 (FGK4.51, Miltenyi), 10-20 µg αIgM (Goat polyclonal µ 
chain, Jackson immunoresearch), 75 nM CpG 1826 oligo (IDT), or combinations of these reagents 
for 4 hours in complete RPMI1640 medium and processed for flow cytometry.  
Software and Statistics 
Data visualization and statistical calculations were performed using Prism GraphPad. 
Statistical tests and p values for each experiment are specified in figure legends for a single 
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comparison between two groups, a student’s t-test was used; for multiple comparisons between 
preselected groups, a one way anova test with Holm-Sidek correction for multiple comparisons 
was used; and for multiple comparisons where all groups were compared, a one way anova test 
with a Tukey correction for multiple comparisons was used. Flow cytometry data were analyzed 
with Flowjo.  
GSEA was run on the graphical user interface according to the manufacturers 
recommendations (https://software.broadinstitute.org/gsea/doc/GSEAUserGuideFrame.html) to 
compare the WT and MyD88- RNA-seq data sets using all genes (Subramanian et al., 2005). 
RNA-seq data are publicly available on Gene Expression Omnibus at GSE126849 
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126849.  
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Results 
TLR9 agonist complexed to T-dependent antigen increases the frequency and number of germinal 
center B cells in response to immunization. 
Previous studies have demonstrated that attachment of a TLR7 or TLR9 ligand to an 
antigen can boost the germinal center antibody response (Hou et al., 2011; Rookhuizen and 
DeFranco, 2014). We created two complex antigens composed of biotinylated 4-nitro-3-
phenylacetyl (NP) chicken gamma globulin (CGG) complexed with streptavidin and either 
biotinylated CpG deoxyoligonucleotide (CpG) or biotinylated control deoxyoligonucleotide (Non) 
yielding NP-CGG-CpG or NP-CGG-Non respectively (Rookhuizen and DeFranco, 2014). 
C57BL/6 mice were immunized subcutaneously with either NP-CGG-CpG or NP-CGG-Non and 
the GC response was analyzed at day 14 (D14) (Fig. S3.3.1A). As the high affinity anti-NP 
antibody response to NP-CGG is known to have a substantial contribution of  light chain-
containing antibodies, we also analyzed the frequency of NP-binding, + GC B cells. Mice 
immunized with the NP-CGG-CpG showed a 3.5 -fold increase in the number of total GC B cells 
(CD19+, IgDlo, Fas+) as well as a 4-fold increase in the number of NP-binding λ+ GC B cells (Fig. 
S3.3.1B/1C). These results agree with a previous study using a similar complex antigen 
(Rookhuizen and DeFranco, 2014). 
To specifically test the role of TLR9 agonism in the B cell compartment, we immunized B 
cell lineage-specific MyD88-deficient Mb1-cre+MyD88fl/fl (B-MyD88-) and control Mb1-cre+ 
MyD88fl/+ or Mb1-cre+ MyD88+/+ (WT) mice with NP-CGG-CpG antigen and analyzed the GC 
response at D14 (Fig. S3.3.1D/E). WT mice exhibited a 2.4-fold higher frequency and number of 
GL7hi GC B cells as compared to the B-MYD88- mice (Fig. 3.1A). Thus in agreement with 
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previous work, these results show that B cell TLR9 signaling enhances the GC response to a 
haptenated antigen attached to a TLR9 ligand. There was also likely to be some contribution of 
TLR signaling in another cell type, such as classical dendritic cells. 
NP-CGG-CpG antigen induces MyD88-dependent c-Myc and mTORC1 signature gene expression 
 To determine the effect of TLR9 signaling on the GC response at a transcriptional level, 
we performed mRNA-sequencing on NP-binding WT and B-MYD88- GC B cells at D14 post 
immunization with NP-CGG-CpG using the gating strategy illustrated in Fig. S3.1E. This analysis 
uncovered 479 differentially expressed genes (FDR<0.05 by Fisher exact test, Table S3.1), of 
which 260 were increased in WT and 219 were increased in B-MYD88- cells. Among the genes 
with higher expression in WT GC B cells many corresponded to ribosomal proteins, NADH 
dehydrogenase, ATP synthase, and cytochrome oxidase machinery pointing towards increased 
oxidative phosphorylation activity (Fig. 3.3A). This metabolic phenotype is consistent with the 
recent finding that TLR9 signaling can rescue naïve B cells from apoptosis resulting from 
mitochondrial dysfunction elicited by BCR engagement in the absence of CD40 or TLR signals 
(Akkaya et al., 2018b). There was also increased Ighg2c gene expression in WT samples compared 
to B-MYD88- samples, as well as increased expression of Aicda, the gene encoding the activation-
induced cytidine deaminase that is directly involved in somatic hypermutation and in class switch 
recombination (Table 3.1). These results are consistent with the strong effect of the TLR9 ligand 
in promoting class switch to IgG2a/IgG2c (Jegerlehner et al., 2007; Rookhuizen and DeFranco, 
2014). Surprisingly, expression of the transcriptional regulator Bcl6, which directs the germinal 
center fate in B cells, was increased in B-MYD88- GC B cells (Table 3.1). Conversely, mRNA 
encoding the survival factor Bcl2 was higher in WT cells (Table 3.1) suggesting that increased 
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survival may contribute to the increased GC B cell frequency and number in the context of intact 
TLR9/MyD88 signaling.  
To gain greater insight from the mRNA expression data sets, we applied Gene Set 
Enrichment Analysis (GSEA) to the Hallmark gene sets (Subramanian et al., 2005). Gene sets 
enriched in WT compared to B-MYD88- GC B cells included the Myc signature with a normalized 
enrichment score (NES)=2.38 FDR<10-5; the E2F signature with a NES=1.60, FDR= 0.02; and the 
mTORC1 signature with a NES= 1.46, FDR= 0.057 (Table 3.2, Fig. 3.3B). We performed a 
leading-edge analysis on the Hallmark subsets from Table 3.2 and found that the genes driving the 
difference in the context of mTORC1 and c-Myc had very little overlap and thus these two gene 
signatures represented independent enrichments (Fig. S3.3.2). Similarly, independently curated 
mTORC1 (Bilanges et al., 2007) and c-Myc (Zeller et al., 2003) gene sets were also enriched in 
WT compared to B-MYD88- GC B cells (Fig. 3.1D, 1F, Table 3.2). Furthermore, the KEGG 
ribosomal pathway showed a large enrichment in WT GC B cells (Table 3.2). From our RNA-seq, 
Aicda was 2 fold increased in WT compared to B-MYD88- (FDR=0.088) concordant with this 
being positively regulated by mTORC1 signaling (Chiu et al., 2019; Raybuck et al., 2018). In 
contrast, no Hallmark gene sets were enriched in the antigen-specific B-MYD88- GC B cells 
compared to the antigen-specific WT GC B cells (FDR q values greater than 0.25 - data not 
shown). Interestingly both c-Myc and mTORC1 have been implicated as downstream effectors of 
Tfh cell help and their dysregulation negatively impacts the GC response(Calado et al., 2012; 
Dominguez-Sola et al., 2012; Ersching et al., 2017). These results suggest that TLR9-MyD88 
signaling in the antigen-specific GC B cell increases the transcriptional outputs of the MYC and 
mTORC1 pathways, either via direct transcriptional effects or indirectly by enhancing the ability 
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of the GC B cells to interact with Tfh and receive CD40L and cytokine signals, which are known 
to promote these two programs 
 TLR9 signaling in naïve B cells increases c-Myc expression 
To better understand how TLR9 signaling enhances the c-Myc pathway transcriptional 
response, we examined the effect of BCR signaling and TLR9 signaling on c-Myc protein 
expression. First naïve polyclonal B cells were stimulated through the BCR and TLR9 in a linked 
fashion by addition of αIgM bound to streptavidin and biotin-conjugated CpG or Non oligos to 
make the complex artificial antigens αIgM-CpG and αIgM-Non, respectively (Sindhava et al., 
2017). To measure the c-Myc protein expression on a single cell level we crossed a knock-in c-
Myc-GFP protein fusion reporter (Huang et al., 2008) to WT and B-MYD88- mouse strains. We 
stimulated purified naïve Mb1-cre+ MyD88fl/flMyc-GFP+/+ (B-MYD88- Myc-GFP) or WT Mb1-
cre+, MyD88+/+ c-Myc-GFP+/+ (WT -Myc-GFP) splenic B cells with either αIgM-CpG or αIgM-
Non for 24 hours and then analyzed the cells for c-Myc-GFP expression by flow cytometry (Fig. 
3.2A). The presence of a TLR9 ligand attached to the αIgM antibodies greatly enhanced c-Myc 
expression in naïve B cells after 24 hours at which time 90% of WT-Myc-GFP cells stimulated 
with αIgM-CpG were c-Myc-GFP+ (Fig. 3.2B). In contrast, WT-Myc-GFP cells stimulated with 
αIgM-Non, and B-MyD88-Myc-GFP cells stimulated with either αIgM-CpG or αIgM-Non 
exhibited much lower c-Myc induction at this time, with 5-10% c-Myc-GFP+ cells (Fig. 3.2B). 
Less than 2% of unstimulated naïve B cells of either genotype were c-Myc-GFP+. Per cell c-Myc-
GFP abundance was also increased by TLR9/MyD88 signaling, with αIgM-CpG stimulated WT-
Myc-GFP B cells displaying a 4-fold increase in GFP mean fluorescence intensity (MFI) compared 
to αIgM-Non stimulated WT-Myc-GFP and B-MyD88-Myc-GFP cells under either stimulation 
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conditions (Fig. 3.2B). Thus, in naïve B cells, combined antigen receptor and TLR9 signals 
induced c-Myc levels much more strongly than antigen receptor signals alone. 
Attachment of a TLR9 ligand to the antigen increased the frequency of GC B cells expressing c-
Myc protein in a non-cell-intrinsic manner  
We next used the c-Myc-GFP reporter to address the mechanism by which attachment of 
a TLR ligand to CGG increased the c-Myc transcriptional signature in GC B cells. Previous work 
established that CD40L delivered by Tfh cells strongly induces c-Myc expression in Light Zone 
(LZ) GC B cells, which consequently return to the Dark Zone (DZ) and undergo further clonal 
expansion (Calado et al., 2012; Dominguez-Sola et al., 2012). Therefore, we examined c-Myc-
GFP expression in day 14 LZ and DZ phenotype GC B cells, identified by elevated CD86/CD83 
or CXCR4 expression, respectively, from c-Myc-GFP+/+ mice immunized with NP-CGG-CpG or 
NP-CGG-Non antigen (Fig. 3.2C, S3A) (Victora et al., 2012; Victora et al., 2010). Both 
immunization groups had similar distributions of DZ and LZ phenotype cells among GC B cells 
(NP-CGG-CpG: DZ= 51% ± 6% LZ = 41% ± 5%; NP-CGG-Non: DZ 52% ± 10%; = LZ= 44% ± 
9%;) (Fig. S3.3A). In agreement with our sequencing data, the NP-CGG-CpG antigen group had 
a higher percentage (2.7% vs. 1.1%), and a greater mean number (3,000 vs. 1,700) of c-Myc-GFP+ 
GC B cells than did NP-CGG-Non immunized animals (Fig. 3.2D). A majority of c-Myc-GFP+ 
cells exhibited a LZ phenotype for both immunization conditions (NP-CGG-CpG: 66% ± 9%; NP-
CGG-Non: 69.8% ± 13%)(Fig. S3.3B), consistent with previous studies showing enrichment of 
the LZ phenotype (Victora et al., 2010) and localization of c-Myc+ GC B cells to the LZ (Calado 
et al., 2012; Dominguez-Sola et al., 2012).  
To test whether TLR9/MyD88 signaling in the GC B cells contributed to the increased 
frequency of c-Myc-expressing GC B cells seen upon immunization with NP-CGG-CpG we 
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immunized WT-Myc-GFP and B-MyD88-Myc-GFP mice with either one allele or two alleles of 
the c-Myc-GFP fusion reporter and analyzed c-Myc-GFP expression at D14. Interestingly, neither 
the number nor percentage of c-Myc-GFP+ GC B cells were increased in the GC B cells from WT-
Myc-GFP mice compared to the GC B cells from the B-MyD88-Myc-GFP mice (Fig. 3.2E). The 
distribution of LZ and DZ phenotypes of bulk and c-Myc-GFP+ GC B cells were also unaltered by 
the inability of the B cells to signal via MyD88 (Fig. S3.3C). The per-cell c-Myc-GFP MFI was 
also similar in WT-Myc-GFP and B-MyD88-Myc-GFP groups (Fig. S3.3D). Thus, there was a 
non-B cell-intrinsic effect of attaching a TLR9 ligand to NP-CGG on expression of c-Myc-GFP. 
Moreover, these results suggest that the increased c-Myc transcription signature resulting from 
TLR9/MyD88 signaling in GC B cells (Fig. 3.1) may have resulted from a regulatory change in c-
Myc transcriptional activity, rather than an increase in c-Myc protein expression 
 Dual TLR9 and BCR signaling increases phosphorylation of ribosomal protein S6 in naïve B cells 
and in GC B cells.  
Next, we examined whether TLR9/MyD88 signaling in purified naïve splenic B cells leads 
to enhanced Akt/mTOR signaling. Initially, purified naïve splenic B cells were stimulated in vitro 
with αIgM complex antigens as before, and phosphorylation of mTORC1 targets was assessed by 
intracellular staining of permeabilized cells with phospho-specific antibodies and flow cytometry. 
Remarkably, phosphorylation of ribosomal protein S6, at ser240/244 (pS6(ser240/244)) and at 
ser235/236 (pS6(ser235/236), known mTORC1 pathway targets, were almost entirely dependent 
on CpG stimulation in naïve B cells (Fig. 3.3A and S4A). αIgM-CpG stimulated WT cells were 
90% positive for pS6(ser240/244) at 24 hours compared to the 5-15% range seen for WT B cells 
stimulated with αIgM-Non or for B-MyD88- B cells treated with either stimulus (Fig. 3.3B). The 
αIgM-CpG stimulated WT B cells showed the highest pS6(ser240/44) MFI, which was 14 times 
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greater than any other group (Fig. 3.3B). Cell size is in part dependent upon protein content of the 
cell and WT B cells stimulated with αIgM-CpG also showed the largest increase in cell size (FSC-
A) compared to the three other groups (Fig. 3.3B), which is consistent with a role of mTORC1 in 
enhancing global protein synthesis.  
Next, we examined the effect of including a TLR9 ligand attached to NP-CGG on the size 
of GC B cells and on their pS6 phosphorylation status. GC B cells were substantially larger than 
naïve B cells as would be expected, but no differences in cell size were evident when comparing 
B-MyD88- and WT GC at D14 post immunization with NP-CGG-CpG antigen (Fig. 3.3C). 
Additionally, no difference in cell size was evident when only NP-binding GC B cells of these two 
genotypes were compared (Fig. 3.3C). Utilizing phospho-flow cytometry we analyzed 
pS6(ser240/244) and pS6(ser235/236) in GC B cells. There was an increase in pS6(ser240/244) 
MFI of WT compared to B-MyD88- GC B cells that was significant (p=0.021) (Fig. 3.3D). 
However, we found that WT and B-MyD88- GC B cells exhibited similar MFI staining for 
pS6(ser235/236) (Fig. S3.4B). When mice were immunized with NP-CGG-CpG vs NP-CGG-Non, 
we found a 2 fold increase in both pS6(ser240/244) (Fig.3E) and pS6(ser235/236) in GC B cells 
(Fig. S3.4C). Interestingly we saw an increase in the pS6 level of non-GC B cells in the NP-CGG-
CpG immunized mice compared to NP-CGG-Non, indicating that another CpG responsive cell 
type alters the metabolic and inflammatory environment of the lymph node increasing mTORC1 
activity in non-GC B cells in a non-cell intrinsic manner. Thus, combined CpG-induced TLR 
signaling and BCR signaling positively regulated mTORC1 signaling robustly in naïve B cells, 
and while all GC B cells had evidence of active mTORC1 signaling, consistent with previous 
studies (Ersching et al., 2017; Jones et al., 2016; Zhang et al., 2013) TLR9/MyD88 signaling 
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appeared to further increase phosphorylation of the mTORC1 target pS6 by both B cell intrinsic 
and extrinsic mechanisms.  
Ex vivo stimulation of GC B cells with CpG oligonucleotide increases mTORC1 phosphorylation 
targets and c-Myc induction similarly to CD40 stimulation 
To test whether TLR signaling ex vivo in GC B cells would enhance mTORC1 signaling 
and c-Myc expression in the absence of continued Tfh cell interaction, GC B cells were isolated 
from immunized Eµ-BCL2 transgenic mice (to promote their survival during in vitro culture) and 
stimulated with αCD40, αIgM, αIgM + CpG oligo, or αCD40 + αIgM for 4 hours, and fixed before 
staining for pS6(ser240/244). It was previously reported that both αIgM and αCD40 signaling are 
necessary to increase mTORC1 activity and induce c-Myc expression in GC B cells, whereas naïve 
B cells respond to either stimulus individually (Luo et al., 2018). Similarly, we found that 
stimulation of naïve B cells with αIgM and/or αCD40 for 4 hours led to at least 90% of cells being 
pS6(ser240/244) positive (Fig. 3.4A-4B). Furthermore, CpG stimulation led to 75% of naïve cells 
being pS6(ser240/244) positive, and the addition of αIgM increased the response to >95% 
pS6(ser240/244) positive (Fig. 3.4A-4B). In contrast, ex-vivo stimulation of Eµ-BCL2 transgenic 
GC B cells with αIgM alone failed to induce increased phosphorylation of this residue compared 
to unstimulated GC B cells (Fig. 3.4A-B). Either αCD40 or CpG oligo stimulation conditions 
increased the percentage of pS6(ser240/244) positive Eµ-BCL2 GC B cells to comparable levels 
(50-60%) (Fig. 3.4A-4B). These results demonstrate that TLR9 stimulation and CD40 engagement 
can have similar effects on mTORC1 signaling in GC B cells. Furthermore, stimulation of the 
BCR via αIgM did not increase the response to αCD40 or CpG oligonucleotide in the Eµ-BCL2 
GC B cells.  
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Next, we crossed the c-Myc-GFP+/+ mice to the Eµ-BCL2 transgenic mice to facilitate 
examination of c-Myc expression in naïve and GC B cell stimulated ex vivo. Naïve c-Myc-
GFP+/WT B cells and c-Myc-GFP+/WT Eµ-BCL2 GC B cells were stimulated with αIgM, αCD40 or 
CpG oligonucleotides or combinations thereof. All stimulation conditions increased the expression 
of c-Myc-GFP substantially in the naïve B cells (MFI increased by αIgM 2.4-fold, αCD40 2.0-
fold, CpG 1.7-fold, αIgM + αCD40 3.7-fold, αIgM + CpG 3.8-fold, compared to no stimulation), 
which is congruent with previous studies demonstrating that CpG induces c-Myc expression in 
immature and naïve B cells (Arunkumar et al., 2013; Azulay-Debby et al., 2007). Thus, c-Myc 
induction in naïve cells was responsive to each stimulus individually and exhibited an additive 
response to multiple stimuli. For the Eµ-BCL2 GC B cells, ex vivo αIgM stimulation did not 
induce c-Myc expression above the unstimulated control (1.1 fold increase in MFI) (Fig. 3.4C, 
4D), similarly to what was seen with phosphorylation sites on ribosomal protein S6. In contrast, 
stimulation with CpG oligonucleotide or αCD40 induced small but significant increases in c-Myc-
GFP expression (MFI increased by 1.3-fold, p=.0007; and 1.2-fold p=0.0013, respectively, 
compared to no stimulation. Addition of αIgM may have further increased c-Myc-GFP expression, 
but it was not statistically significant compared to the individual stimulations. Thus we did not see 
a clear synergy between αIgM and αCD40 stimulation for the induction of c-Myc expression or 
mTORC1 signaling, in contrast to a previous report (Luo et al., 2018). As both c-Myc expression 
and phosphorylation of a key mTORC1 target were increased to similar levels upon stimulation of 
GC B cells with αCD40 or CpG oligonucleotide, it is possible that TLR9 signaling in GC B cells 
could be a partial surrogate for CD40 mediated Tfh cell help. According to this interpretation, 
more GC B cells would get pro-survival mTORC1 signaling and c-Myc induction in the context 
of TLR9 signaling in the GC, lowering the need for CD40 stimulation and Tfh cell help. This 
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would increase the number of cells that survive and the pool of GC B cells as a percentage of the 
B cell population.  
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Discussion 
Previous work established that a TLR ligand attached to a haptenated-protein antigen or 
contained within a virus particle can promote the magnitude and quality of the GC reaction and 
moreover that TLR signaling within the antigen-specific B cell is an important contributor to that 
enhancement (Hou et al., 2011; Rookhuizen and DeFranco, 2014). Here, we used mRNA 
sequencing and GSEA to identify the intracellular transcriptional programs that were enhanced by 
coupled antigen and TLR9/MyD88 signaling in GC B cells. Especially enhanced were the 
transcriptional signatures associated with c-Myc transcriptional activity and mTORC1 signaling. 
Both of these pathways are central to the control of cell growth and proliferation in many cell types 
and are critical in B cells for the GC response (Calado et al., 2012; Jones et al., 2016; Zhang et al., 
2013). Interestingly, Tfh cells recognizing antigen presented by GC B cells also stimulate these 
pathways in the antigen-presenting GC B cell, leading to positive selection of the GC B cells 
(Dominguez-Sola et al., 2012; Ersching et al., 2017; Mayer et al., 2017). Thus, one potential 
mechanism by which TLR9/MyD88 signaling may have enhanced c-Myc transcription and 
mTORC1 signaling is by enhancing interactions of GC B cells with Tfh cells. Alternatively, 
TLR9/MyD88 signaling in the antigen-specific B cells may have directly increased the 
transcriptional activities of one or both of these pathways. Consistent with the latter, direct 
mechanism, we found that ex vivo stimulation of Bcl2-transgenic GC B cells with a TLR9 ligand 
increased expression of a c-Myc-GFP protein reporter and increased phosphorylation of the 
mTORC1 target protein ribosomal protein S6, in both cases similarly to the response induced by 
anti-CD40, which mimics a key aspect of helper T cell action. 
It is likely that several mechanisms contributed to the enhanced c-Myc transcriptional 
activity seen in antigen-specific GC B cells responding to NP-CGG-CpG immunization. Both 
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naïve B cells and Bcl2-transgenic GC B cells cultured ex vivo and stimulated with a TLR9 ligand 
oligonucleotide exhibited increased c-Myc-GFP protein reporter induction, indicating direct 
TLR9/MyD88 signaling can induce elevated levels of c-Myc protein. Moreover, MyD88 signaling 
has been shown to stabilize c-Myc protein in intestinal epithelial cells (Lee et al., 2010). However, 
the increase in c-Myc-GFP expression in vivo after immunization with the NP-CGG-CpG 
conjugate was seen not only in wild type mice but also in mice in which MyD88 was deleted 
selectively in B cells, indicating that the observed increase in c-Myc-GFP can also occur by an 
indirect mechanism, mostly likely by induction following cognate interactions with antigen-
specific Tfh cells. This indirect mechanism of promoting c-Myc protein expression in GC B cells 
could result from TLR9 signaling in other cell types, such as conventional dendritic cells - or 
stromal cells such as follicular dendritic cells (FDCs). Indeed, previous studies showed that TLR9 
signaling in dendritic cells enhanced the number of Tfh cells following immunization with NP-
CGG-CpG (Rookhuizen and DeFranco, 2014), possibly indicating increased availability of Tfh 
cell help for GC B cells. Interestingly, c-Myc protein levels were similar in WT and MyD88- GC 
B cells immunized with NP-CGG-CpG, whereas the c-Myc transcriptional program was stronger 
in the former mice. The lack of concordance between gene expression data in sorted GC B cells 
and c-Myc-GFP fluorescent reporter expression indicates that c-Myc-dependent transcription is 
not necessarily directly proportional to c-Myc protein levels in GC B cells. Therefore, differences 
in the c-Myc-driven transcriptional signature could be orchestrated through c-Myc 
phosphorylation, binding partners, or chromatin accessibility (Conacci-Sorrell et al., 2014; Wang 
et al., 2011) programmed in activated B cells by dual BCR/TLR9 signaling that persists into the 
GC fate. This GC B cell-intrinsic enhancement of c-Myc transcriptional activity would perhaps 
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enhance the effect of Tfh induction of c-Myc protein by making that c-Myc more active and driving 
higher levels of gene expression, accounting for the transcriptional profiling results. 
The increased mTORC1 transcriptional signature identified by GSEA in GC B cells of 
mice immunized with NP-CGG-CpG was mirrored by increased phosphorylation of ribosomal 
protein S6, a downstream target of mTORC1. While the MyD88- GC B cells showed a subtle 
defect in ribosomal protein S6 phosphorylation in vivo, the remaining observed response in these 
cells could have been due to CD40 stimulation resulting from cognate interactions with Tfh cells. 
In addition, we observed that ex vivo stimulation of GC B cells with a TLR9 ligand also induced 
an increase in phospho-S6 in the GC B cells, indicating that the NP-CGG-CpG likely also directly 
stimulated this pathway in wild type GC B cells. Previous studies have demonstrated MyD88-
mediated mTORC1 activation and binding in innate immune cells, and a similar process could 
occur in GC B cells (Schmitz et al., 2008).  
While TLR agonists can promote both T-independent and T-dependent antibody responses, 
the nature of the antigen and the presence of additional adjuvants can have a major impact on the 
contribution of TLR signaling to the response. Previous work has shown that the valency of the 
antigen and its propensity to cross-link the BCR dictates the impact of B cell intrinsic MyD88-
mediated signaling in shaping the GC response. Immunization with monovalent T-dependent 
antigens (such as ovalbumin) fused to CpG oligo show no difference in GC B cell numbers or 
antibody titers between B-MyD88- and WT mice (DeFranco et al., 2012; Hou et al., 2011), whereas 
B-MyD88- mice immunized with multi-valent VLPs have a profound deficit in the GC response 
and antibody titers compared to WT mice (Hou et al., 2011; Tian et al., 2018). Furthermore, 
addition of the lipid adjuvant DOTAP in conjunction with CpG oligonucleotide and NP-CGG, 
forming a multivalent particulate antigen, increased GC B cell and Tfh numbers as well as both 
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high affinity and low affinity NP-specific antibody titers when compared to immunization with 
CpG oligonucleotide and NP-CGG in soluble form (Akkaya et al., 2017). However, when the same 
group performed experiments with CpG oligonucleotide and NP-CGG complexed with alum, they 
saw a decrease in high affinity antibody titers against NP in WT mice compared to B-MyD88- 
mice (Akkaya et al., 2018a). Moreover, the inclusion of alum to complex a large murine self CpG 
DNA molecule with an amyloid conformed protein (chemically modified human serum albumin) 
also diminished total GC number and total anti-HSA titers (Sindhava et al., 2017). These 
differences demonstrate that the exact conformation of the protein CpG oligo complex and other 
adjuvants, specifically alum, can profoundly affect the quality and quantity of the humoral 
response. The inclusion of alum and its inflammasome-mediated adjuvant activity in monocytes 
(MacLeod et al., 2011; McKee and Marrack, 2017) could be a complicating factor in these two 
experimental settings in which a decrease in the GC response was observed.  
While it is clear that TLR9 signaling in B cells can substantially promote the GC response 
(Akkaya et al., 2017; Rookhuizen and DeFranco, 2014; Tian et al., 2018), the exact timing of when 
TLR9-mediated MyD88 signaling influences the GC fate has not been well defined. This signaling 
event during early B cell activation could provide a selective advantage for initiating the GC or 
alternatively, TLR9/MyD88 signaling event in GC cells could directly enhance their ongoing 
participation in the GC reaction. The enhanced c-Myc and mTORC1 transcriptional programs seen 
in GC B cells on d14 are certainly consistent with the latter possibility, but these possibilities are 
not mutually exclusive. In our in vivo and ex vivo stimulation experiments, both naïve and GC B 
cells responded directly to TLR9 stimulation by upregulating mTORC1 signaling and c-Myc 
protein expression. However, recent studies have demonstrated that MyD88 signaling during the 
initial activation of naive B cells in the response to nucleic acid-containing VLPs also plays a key 
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role in activated B cell survival, proliferation, and antigen presentation to cognate T cells (Akkaya 
et al., 2018b; Hong et al., 2018). Furthermore, deletion of Myd88 in activated B cells utilizing 
Aicda-cre had a lesser effect than deletion of Myd88 with Mb1-cre prior to immunization, 
indicating that TLR/MyD88 signaling during the early phase of the response is important in the 
response to CpG-containing VLPs (Tian et al., 2018). This observation bolsters the idea that dual 
BCR and TLR9 signaling in naïve B cells provides a selective advantage that is maintained days 
later in the GC response. Thus, the difference in numbers and percentage of GC B cells could be 
a result of differences in early activation, though our gene expression data indicates that there are 
persistent MyD88-signaling events that are maintained during the GC, at least through day 14.  
Both BCR and co-signaling through TLRs and CD40 have been implicated in the 
metabolic reprogramming of activated B cells. Studies of early activation of B cells in vitro by 
BCR stimulation, TLR4 stimulation with LPS, or CD40 + IL-4 stimulation to mimic helper T 
cell action have implicated increased glycolytic flux and increased oxidative/phosphorylation as 
critical metabolic shifts during the initial activation of naïve cells and for antibody production in 
vitro (Caro-Maldonado et al., 2014; Waters et al., 2018). Interestingly, B cells that receive a BCR-
mediated signal alone undergo toxic mitochondrial reprogramming, leading to apoptosis unless a 
secondary signal such as TLR stimulation or CD40-mediated signaling rescues this metabolic 
dysfunction (Akkaya et al., 2018b). Thus, activation signals in naïve B cells directly reprogram 
the mitochondria and necessitate co-signaling events for survival, however the metabolic 
reprograming that occurs in GC B cells remains largely unknown. As discussed above, it is clear 
that Tfh cell help induces mTORC1 signaling and c-Myc expression (Calado et al., 2012; 
Dominguez-Sola et al., 2012; Ersching et al., 2017), two mediators of metabolism and cell cycle 
regulation. Previous studies have implicated a synergy between BCR stimulation and αCD40 
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mediated Tfh help to induce mTORC1(Luo et al., 2018), and our ex vivo stimulation data supports 
the idea that cosignaling of BCR and TLR9/MyD88 induce mTORC1. In addition, we found that 
TLR9/MyD88 signaling in GC B cells enhanced expression of genes involved in oxidative 
phosphorylation and mitochondrial function (Fig. 3.1B, S3.2, Table 3.2). 
This work adds to our basic understanding of the molecular pathways within the GC B cell 
by which TLR recognition promotes their response and has shown that this involves activation of 
mTORC1 and increased c-Myc transcriptional activity, two critical events also resulting from 
antigen-presentation to Tfh cells. Such understanding may facilitate efforts to improve current 
vaccines or create new effective vaccines by rational approaches. The tight association of a CpG 
oligonucleotide to a protein antigen is in most circumstances sufficient to promote an increased 
humoral immunity and could serve as a strategy for vaccination as can the use of virus-like 
particles containing nucleic acid ligands for TLR9 or TLR7. Such immunogens likely mimic to 
some degree the nature of virus particles and engage an evolutionarily-derived mechanism to 
defend against viral infections. Utilizing endosomal TLR adjuvants to shape the humoral response 
and provide an increased number of GC B cells could be beneficial in anti-viral vaccine 
development. 
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Figure 3.1: mRNA-seq analysis of WT and B-MYD88- NP+ GC B cells shows increased c-
Myc and mTORC1 gene expression signatures 
A Enumeration of GC B cell percentages and total cell numbers from draining lymph nodes of WT 
and B-MYD88- animals at D14 post immunization. Shown is a representative of 4 independent 
experiments with at least 3 mice per group. B Volcano plots comparing gene expression fold 
changes to p value for all genes expressed in at least one sample after DESeq2 analysis. Red dots 
in each panel indicated genes associated with the given metabolic/synthetic complex listed. C 
GSEA plots for Hallmark gene sets for mTORC and c-Myc gene signatures enriched in WT 
transcriptional data. D GSEA plot from curated gene sets showing enrichment of rapamycin and 
serum sensitive genes in WT samples. E GSEA plot from curated gene sets showing enrichment 
of c-Myc target genes in WT samples. 
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Figure 3.2: Dual BCR/TLR9 Signaling positively regulates c-Myc expression in naïve and 
GC B cells. 
A Overlay of representative histograms showing c-Myc-GFP expression in response to αIgM-CpG 
stimulation for 24hs of WT c-Myc-GFP and B-MYD88- c-Myc-GFP naïve B cells. B Enumeration 
of %GFP positive and MFI of cells in A (shown is a single experiment representative of 3 
independent experiments). C Overlay of representative histograms showing GFP fluorescence 
gating on live, singlet, CD19+, Fas+, IgDlo, GL7+ GC cells of c-Myc-GFP+/+ mice immunized with 
NP-CGG-CpG or NP-CGG-Non D14 post immunization. D Enumeration of percent and number 
of GFP+ GC B cells from NP-CGG-CpG and NP-CGG-Non immunized c-Myc-GFP+/+ mice (three 
combined experiments with at least 3 mice per group). E Enumeration of percent and number GFP 
positive cells from NP-CGG-CpG immunized B-MYD88- and WT mice D14 (representative 
experiment of 3 independent experiments). **= p<0.005, ****= p<0.0001, NS = p>0.05 by one-
way ANOVA and Holm-Sidak’s multiple comparison test 
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Figure 3.3: Dual BCR/TLR9 Signaling positively regulates mTORC1 activity measured by 
ribosomal protein S6 phosphorylation in naïve and GC B cells. 
A Overlay of representative histograms showing pS6 ser240/244 levels in response to αIgM-CpG 
for 24 hr.in WT and B-MYD88- naïve B cells. B Enumeration of cell size by forward light scatter 
(FSC-A), % pS6 ser240/244 +, and MFI of those cells gated positively for pS6 ser240/244 cells 
for WT and B-MYD88- naïve B cells stimulated with αIgM-CpG. C Enumeration of cell size from 
D14 NP-CGG-CpG immunized B-MYD88- and WT non-GC and GC B cells (representative of 4 
independent experiments). D phospho-flow MFI of mTORC1 downstream target pS6 ser240/244 
D14 NP-CGG-CpG immunized B-MYD88- and WT B cells normalized to mean of B-MYD88- 
GC MFI (data are combined from 3 experiments with at least 3 mice per group) E phospho-flow 
MFI of mTORC1 downstream target pS6 ser240/244 D14 NP-CGG-CpG and NP-CGG-Non 
immunized mice normalized to mean MFI of NP-CGG-Non MFI (combined from 2 independent 
experiments with at least 4 mice per condition). ****= p<0.0001, NS = p>0.05 by one-way 
ANOVA and Holm-Sidak’s multiple comparison test. 
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Figure 3.4: CpG Stimulation of GC B cells ex vivo increases mTORC1 signaling to similar 
levels as αCD40 stimulation. 
A Representative histograms comparing phosphoflow pS6 ser240/244 staining of 4 hour ex vivo 
stimulated naïve and GC B cells isolated from i.p. NP-CGG alum immunized mouse spleens at 
D12-D14 (3 mice per experiment performed in 3 separate experiments). B Enumeration of 
experiments from A showing level of pS6 ser240/244 expression in Naive and GC B cells from A. 
C Overlays of c-Myc-GFP expression comparing no stimulation to the respective stimulation in 
Naïve and GC B cells after 4 hours. D Enumeration of the relative c-Myc-GFP MFI increase 
normalized to no stimulation of the samples in C (representative of 3 independent experiments 
with at least 3 mice per experiment). *= p<0.05, ****= p<0.0001, and NS = p>0.05 by one-way 
ANOVA and Tukey’s multiple comparison test. 
  
 
 
101 
 
 
 
 
102 
 
Supplemental Figure 3.1: Chemical and Genetic approach to studying TLR9 agonist in the 
GC. A Experimental design for immunizing C57BL/6J mice with complex NP-CGG-CpG and 
NP-CGG-Non antigen. B Example flow cytometry plot showing gating strategy from live, singlet, 
dump , CD19+ cells using Fas+, IgDlo followed by NP(8-14)-PE and λ light chain positive. C 
Enumeration of the number of GC and NP+, λ+ GC cells in  immunized mice at D14. *= p<0.05 
by Student’s t test. D Experimental design for immunizing WT or B-MyD88- mice with complex 
NP-CGG-CpG antigen. E Gating strategy comparing WT and B-MYD88- live, singlet, dump-, 
CD19+ GC (Fas+, IgDlo, GL7+) cells and the resulting NP+ and negative populations. Large 
variability in NP-binding led to no significant difference in the NP+, λ+ population GC B cells 
(data not shown). 
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Supplemental Figure. 2: Leading edge analysis of 7 Hallmark gene sets found to be 
upregulated in WT compared to B-MYD88- GC B cells. A Each gene listed is in at least one of 
the 7 data sets. Color from white to red shows relative level of mRNA expression. B Color from 
white showing no overlap to dark green demonstrating complete overlap for the 7 gene sets. 
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Supplementary Figure 3.3: Gating strategy for DZ and LZ populations in the GC and 
numeration of these populations using both experimental strategies. A DZ and LZ gating 
strategy for GFP+ and bulk GC B cells. B Enumeration of DZ and LZ breakdown of GFP positive 
and bulk GC populations in NP-CGG-CpG and NP-CGG-Non immunized mice at D14 (3 
combined experiments with at least 3 mice in each group). C Enumeration of DZ and LZ 
distribution of GFP positive and bulk GC populations in B-MYD88- and WT mice immunized 
with NP-CGG-CpG at D14 (3 combined experiments with at least 3 mice in each group). D MFI 
of GFP positive GC cells from C. NS = p>0.05 by student’s t test. 
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Supplementary Figure 3.4: Complimentary analysis for pS6 ser235/236 for in vitro complex 
antigen stimulation and in vivo immunizations. 
A Enumeration of % pS6 ser235/236 +, for WT and B-MYD88 - naïve B cells stimulated in vitro 
with αIgM -CpG and αIgM-Non for 24 h ours. ****= p<0 .001 by Student’s t test. 
B phospho-flow MFI of mTORC1 downstream target pS6 ser235/236 of D14 NP-CGG -CpG 
immunized B-MYD88 - and WT B cells normalized to mean of B-MYD88 - GC MFI (3 combined 
experiments with at least 3 mice per group). C phospho-flow MFI of mTORC1 downstream target 
pS6 ser235/236 of D14 NP-CGG-CpG and NP-CGG-Non immunized m ice normalized to mean 
NP-CGG-Non MFI . **= p<0.0 05, ** * = p<0.0005, ****= p<0.00 01, NS = p>0.05 by one-way 
ANOVA and Holm-Sidak’s multiple comparison test. 
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Table 3.1: B Cell Activation, CSR, and Cell Fate Gene Expression 
Gene Log2(KO/WT) Raw p value FDR value 
Ighg2c -0.931278014 2.63E-06 0.000742214 
Fas 0.141497226 0.364147352 0.93944051 
Cxcr4 0.364550474 0.115060865 0.6353624 
Cd86 -0.155604203 0.313582804 0.90908692 
Cd80 -0.247780304 0.381587211 0.93944051 
Aicda -0.516289592 0.002956723 0.08882857 
Prdm1 -1.091192869 0.003046472 0.08996182 
Tlr9 0.115035034 0.502823401 0.97633773 
Myd88 -1.7156157 2.80E-05 0.00412237 
Bcl6 0.39066445 0.000556044 0.03277441 
Bcl2 -1.081316005 0.000697559 0.03849734 
 
  
 
 
109 
 
Table 3.2: GSEA shows enrichment for mTORC1 and Myc signatures 
NAME SIZE ES NES NOM p-val 
FDR q-
val 
HALLMARK_OXIDATIVE_ 
PHOSPHORYLATION 186 0.593 2.91 >1E-04 >1E-04 
HALLMARK_MYC_TARGETS_V1 191 0.487 2.38 >1E-04 >1E-04 
HALLMARK_REACTIVE_OXYGEN_ 
SPECIES_PATHWAY 45 0.517 1.96 >1E-04 
4.17E-
04 
HALLMARK_PANCREAS_BETA_ 
CELLS 24 0.537 1.76 8.65E-03 
8.19E-
03 
HALLMARK_DNA_REPAIR 134 0.360 1.71 >1E-04 
1.01E-
02 
HALLMARK_E2F_TARGETS 191 0.327 1.60 >1E-04 
2.10E-
02 
HALLMARK_UNFOLDED_PROTEINRE
SPONSE 104 0.332 1.49 1.59E-02 
4.61E-
02 
HALLMARK_MTORC1_SIGNALING 189 0.299 1.46 4.77E-03 
5.65E-
02 
DANG_MYC_TARGETS_UP 129 0.493 2.29 >1E-04 >1E-04 
KEGG_RIBOSOME 72 0.819 3.45 >1E-04 >1E-04 
BILANGES_SERUM_AND_ 
RAPAMYCIN_SENSITIVE_GENES 59 0.727 2.95 >1E-04 >1E-04 
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Supplemental Table 3.1:  Differential Genes from RNA-seq of 
B-MyD88-(KO) vs WT NP+, GC B cells 
Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
1110038F14Rik -1.0765 1.653E-04 0.014651942 
1700017B05Rik 0.8342 1.900E-06 0.000583898 
1700039E15Rik 3.6174 6.640E-06 0.001400288 
1810058I24Rik -1.2067 1.330E-06 0.000451313 
2010107E04Rik -1.1014 1.430E-05 0.002481323 
2210406O10Rik 6.9776 2.710E-05 0.004033915 
2310022B05Rik 1.1578 6.068E-04 0.034464025 
2610507I01Rik -1.8086 4.383E-04 0.028623241 
2700094K13Rik -0.8576 9.553E-04 0.047603974 
4930404N11Rik -2.5629 1.200E-05 0.002171875 
4930565N06Rik 1.6401 5.040E-06 0.001138243 
4931414P19Rik 1.9676 6.790E-04 0.037829611 
8430429K09Rik -0.9238 4.729E-04 0.029544915 
A4galt 3.1500 8.751E-04 0.045405681 
Abca3 0.4743 5.136E-04 0.031213796 
Abcc1 0.6749 2.129E-04 0.017295532 
Abhd14b 1.7158 1.018E-03 0.049739221 
Abracl -0.9999 7.220E-04 0.039290757 
Acp5 -0.9287 1.060E-05 0.001968641 
Actl6b -8.8456 5.764E-04 0.033549234 
Adat1 0.8209 5.120E-05 0.006467641 
Ago2 0.3623 9.774E-04 0.048445584 
Aldh2 -0.7381 8.080E-07 0.000320533 
Alg3 0.8949 4.787E-04 0.029790242 
Amotl1 2.4874 2.590E-07 0.000144311 
Anapc13 -1.4889 9.820E-07 0.000370441 
Ankmy1 4.1605 2.051E-04 0.016838252 
Arel1 0.4228 2.367E-04 0.018773841 
Arid1a 0.4329 2.745E-04 0.021058997 
Armc2 -8.6723 2.500E-06 0.000722975 
Arpc3 -0.5500 3.158E-04 0.02294815 
Arpp21 6.8774 4.578E-04 0.029094005 
Asf1a -0.5709 1.601E-04 0.014316035 
Asnsd1 -1.3092 5.170E-06 0.001151389 
Atcay 2.1018 2.610E-05 0.003916278 
Atg16l1 0.5043 3.529E-04 0.024872335 
Atg5 -0.6688 7.923E-04 0.042231252 
Atp5c1 -0.6045 1.070E-05 0.001968641 
Atp5d -0.7971 7.644E-04 0.041214432 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Atp5e -1.2132 2.780E-10 6.74E-07 
Atp5g3 -0.7529 3.240E-06 0.000824676 
Atp5j -0.6899 6.870E-07 0.000281867 
Atp5j2 -0.8049 2.670E-06 0.000744799 
Atp5k -1.7238 4.920E-10 1.05E-06 
Atp5sl 0.7965 8.300E-06 0.001673692 
Atp6ap1 0.6728 4.560E-06 0.001055953 
Atp7b -3.2165 2.981E-04 0.022097454 
Atxn2 0.6083 8.820E-06 0.001720336 
Bace1 0.5842 1.494E-04 0.013929904 
Bank1 -0.5621 2.459E-04 0.019376971 
Bcl2 -1.0813 6.976E-04 0.03849734 
Bcl6 0.3907 5.560E-04 0.032774406 
Bhlhe41 -0.8016 8.482E-04 0.04455924 
Blvrb -0.5208 4.401E-04 0.028623241 
Bora 0.4773 4.587E-04 0.029094005 
Brk1 -0.8303 9.600E-07 0.000368208 
Btg1 -0.6675 7.835E-04 0.041953654 
C530005A16Rik 1.6945 1.250E-05 0.00223014 
C78197 8.7523 6.390E-08 4.82E-05 
Camkmt -2.0795 1.920E-05 0.003000426 
Cand2 0.7249 1.584E-04 0.014316035 
Ccdc12 -1.1649 7.070E-05 0.008073327 
Ccdc150 6.2158 9.947E-04 0.048798368 
Ccdc181 -0.6987 1.476E-04 0.013818668 
Cd36 -1.0168 7.600E-05 0.008472882 
Cd52 -0.9132 3.240E-06 0.000824676 
Cd72 -0.9570 1.572E-04 0.014316035 
Cd8a 2.6972 2.012E-04 0.016578196 
Cend1 6.9094 3.825E-04 0.026111812 
Cenph -0.5172 3.765E-04 0.025834217 
Chchd1 -1.3564 1.210E-05 0.002178688 
Chchd10 -0.8921 2.860E-12 1.87E-08 
Chchd2 -0.9520 7.206E-04 0.039290757 
Chchd4 -0.8634 3.754E-04 0.025834217 
Cib1 -0.8042 5.306E-04 0.031836845 
Cks1b -0.6931 4.780E-05 0.006289102 
Clcn6 0.6734 8.323E-04 0.043961925 
Cnppd1 0.9037 5.135E-04 0.031213796 
Col27a1 2.1316 1.541E-04 0.014308277 
Col2a1 -6.0805 1.826E-04 0.015822329 
Cox4i1 -0.7508 5.956E-04 0.034157962 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Cox5b -0.7359 6.912E-04 0.038329416 
Cox6a1 -0.6589 5.444E-04 0.032249318 
Cox6b1 -0.9579 5.230E-09 6.44E-06 
Cox6c -1.1395 2.830E-07 0.000151328 
Cox7a2 -1.0844 6.990E-05 0.008058411 
Cox7a2l -0.9066 5.390E-08 4.35E-05 
Cox7b -0.9642 1.710E-06 0.00054866 
Crip1 -1.2932 2.430E-11 9.49E-08 
Cript -0.5869 2.701E-04 0.020794843 
Crocc 1.0387 1.082E-04 0.011198418 
Csf3r 6.5603 3.316E-04 0.023874915 
Csrp1 0.5208 4.832E-04 0.029992006 
Cuta -0.6388 3.837E-04 0.026111812 
Cxcr3 -1.1198 2.880E-10 6.74E-07 
Cxxc5 0.6463 3.722E-04 0.025834217 
Cyb5a -1.0595 5.290E-06 0.001168061 
Cyba -0.9666 5.980E-06 0.001283323 
D430018E03Rik 2.8182 8.493E-04 0.04455924 
D7Ertd715e 0.8068 5.908E-04 0.034006058 
D830044I16Rik 4.6222 6.616E-04 0.036969625 
Dbi -0.8166 1.020E-06 0.00037766 
Ddias 0.8861 3.556E-04 0.024911011 
Ddit4 -1.4781 3.110E-06 0.000808821 
Decr2 1.2238 8.420E-05 0.009255164 
Dhx35 0.6081 8.628E-04 0.044964952 
Dnaic2 3.8653 2.359E-04 0.018773841 
Dnajc8 -0.4318 1.603E-04 0.014316035 
Dock3 6.8496 1.219E-04 0.01219086 
Dock9 0.6013 3.670E-06 0.000914093 
Dtnbp1 -0.7108 3.670E-05 0.005241212 
Edf1 -0.7876 3.740E-05 0.005271163 
Eef1b2 -0.6445 3.438E-04 0.024381385 
Efhc2 7.0358 1.923E-04 0.016183437 
Eif1b -1.0850 3.524E-04 0.024872335 
Eif3k -0.5966 4.650E-04 0.029405901 
Elof1 -1.0343 9.410E-05 0.01019215 
Eno1 -0.4554 8.891E-04 0.045884852 
Entpd1 -1.8762 6.910E-06 0.001421219 
Epha2 7.0624 3.012E-04 0.022195652 
Evc 2.0085 5.060E-06 0.001138243 
Eya1 1.0107 2.850E-07 0.000151328 
Faim3 -0.5191 4.916E-04 0.030350114 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Fam101a 1.6361 2.903E-04 0.021916498 
Fam162a -0.8300 4.419E-04 0.028623241 
Fam65a 0.5877 7.239E-04 0.039300855 
Fam96b -1.5495 3.380E-07 0.000175758 
Farsa 0.9069 1.180E-04 0.012004012 
Fastk 0.7726 2.640E-08 2.47E-05 
Fat1 3.9772 8.980E-06 0.001736816 
Fgl2 -0.8424 9.800E-05 0.010379162 
Fnta -0.7390 1.439E-04 0.013698763 
Foxk1 0.5517 6.390E-05 0.007550317 
Foxred2 0.9637 1.900E-05 0.002979471 
Fth1 -0.9710 1.260E-08 1.34E-05 
Fundc2 -0.6213 5.989E-04 0.034182077 
Gab1 -8.7409 8.166E-04 0.043329649 
Gab2 4.9689 2.460E-06 0.000720777 
Gas5 -0.4274 5.778E-04 0.033549234 
Gimap7 -0.9184 5.980E-09 6.99E-06 
Gm10524 0.8719 8.855E-04 0.045840909 
Gm11510 2.1744 2.957E-04 0.022034196 
Gm11831 4.0517 7.803E-04 0.041878732 
Gm12158 0.8238 6.868E-04 0.038172829 
Gm12917 4.6249 8.319E-04 0.043961925 
Gm13351 1.5329 2.002E-04 0.016552299 
Gm13873 -8.1103 2.415E-04 0.01909405 
Gm15367 6.6092 9.048E-04 0.046226851 
Gm15551 2.5991 9.086E-04 0.046321776 
Gm15780 7.6744 3.880E-05 0.00543332 
Gm15832 3.8695 2.546E-04 0.019925951 
Gm15842 2.2579 1.404E-04 0.013629926 
Gm15932 6.5219 9.917E-04 0.048798368 
Gm16853 3.6628 4.690E-05 0.006205008 
Gm17275 0.6879 6.300E-07 0.000263141 
Gm21982 6.6941 1.945E-04 0.016193537 
Gm23639 -4.3364 9.570E-05 0.010267533 
Gm24636 5.1848 5.915E-04 0.034006058 
Gm26049 1.4432 3.300E-05 0.0047633 
Gm26518 1.5181 6.541E-04 0.036703527 
Gm26847 3.5100 6.939E-04 0.038383653 
Gm26917 0.8068 9.557E-04 0.047603974 
Gm6225 2.9477 7.886E-04 0.042131632 
Gm7741 -2.4921 5.597E-04 0.032909031 
Gm8428 3.1306 4.999E-04 0.030621805 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Gmnn -0.5509 7.107E-04 0.038945758 
Gng5 -0.8278 4.418E-04 0.028623241 
Gon4l 0.5649 8.902E-04 0.045884852 
Gorab 1.2249 1.640E-05 0.002637094 
Gpx1 -0.6137 7.364E-04 0.039842021 
Grhl1 1.2723 2.916E-04 0.021942221 
Gtf2h4 -0.8898 1.300E-04 0.012940479 
H2afv -0.7579 1.958E-04 0.016246527 
H2afy3 2.7394 1.922E-04 0.016183437 
H6pd 2.2192 5.590E-05 0.006808762 
Hbb-bt -1.5492 1.950E-06 0.000591425 
Hdac6 0.7128 4.019E-04 0.026960996 
Hddc2 -0.8466 1.349E-04 0.013188907 
Helz2 0.4356 3.691E-04 0.025708041 
Hint1 -1.0847 1.360E-05 0.002387967 
Hip1 1.3434 8.590E-06 0.001689613 
Hlx -7.9635 3.750E-04 0.025834217 
Hmga1 0.5971 5.500E-05 0.006732969 
Hscb -0.8079 4.284E-04 0.028315653 
Ier3ip1 -1.0133 4.178E-04 0.027775111 
Ifitm2 7.4695 8.790E-05 0.009612004 
Ift20 -0.6938 1.590E-05 0.002608299 
Ighg2c -0.9313 2.630E-06 0.000742214 
Ighj3 -1.2035 9.300E-06 0.001784636 
Ighv1-36 -8.7122 3.820E-11 1.28E-07 
Ighv1-81 -2.6671 1.749E-04 0.01538845 
Igkv1-117 -2.5787 3.649E-04 0.025490643 
Igkv2-137 -5.0789 7.700E-10 1.50E-06 
Igkv3-5 -4.0583 2.898E-04 0.021916498 
Igkv4-56 -5.0126 9.199E-04 0.046692079 
Igkv4-92 -9.1221 2.060E-04 0.016850441 
Igkv5-45 -6.0949 2.180E-08 2.13E-05 
Igkv8-19 -3.6130 9.942E-04 0.048798368 
Igkv9-124 -2.9947 1.660E-05 0.002638288 
Igkv9-129 -5.8406 3.937E-04 0.026622873 
Iglc2 -0.9531 6.126E-04 0.034709 
Iglv1 -0.9056 3.500E-08 3.15E-05 
Il10ra -1.0473 4.021E-04 0.026960996 
Il18r1 3.1269 2.890E-06 0.000783828 
Il1r2 6.5531 4.403E-04 0.028623241 
Il2rb 0.9049 4.760E-07 0.000218413 
Inf2 0.7756 4.137E-04 0.027583108 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Ing2 -0.6442 9.537E-04 0.047603974 
Ipo4 0.6788 2.910E-06 0.000783828 
Iqcg 3.8828 1.430E-07 9.28E-05 
Itga4 -0.5058 2.606E-04 0.020232397 
Itpkb 0.6644 4.940E-05 0.006387711 
Jtb -0.8271 7.200E-05 0.008142611 
Kat7 0.5510 3.049E-04 0.022294947 
Kif18b 0.7108 4.950E-07 0.000222938 
Klf11 1.4374 1.650E-05 0.002637094 
Lifr -2.4426 8.578E-04 0.044803716 
Lmln 1.9443 1.942E-04 0.016193537 
Lmo2 -0.6469 1.353E-04 0.013188907 
Lmo7 0.4499 1.453E-04 0.013698763 
Lrrc61 0.7846 2.954E-04 0.022034196 
Lrrn3 2.3693 4.517E-04 0.029037179 
Lsm3 -0.7128 1.181E-04 0.012004012 
Lsm4 -0.8247 5.360E-05 0.006638948 
Ltbp3 4.3012 6.620E-04 0.036969625 
Ly6a -1.1402 5.910E-13 6.91E-09 
Ly6k -6.9868 3.470E-07 0.000176538 
Ly86 -0.6502 1.122E-04 0.011553694 
Lyrm4 -1.2520 2.040E-06 0.000611303 
Lyz1 7.4062 5.230E-05 0.006515547 
Malsu1 -1.0333 2.270E-06 0.000672253 
Mapk7 0.6069 2.272E-04 0.018197719 
Mfsd6 0.7817 4.546E-04 0.029094005 
Mif -0.7683 4.735E-04 0.029544915 
Minos1 -1.1133 8.830E-08 5.98E-05 
Mir378b 1.8067 7.743E-04 0.04165293 
Mov10 0.6664 1.194E-04 0.012039275 
Mrgpre -0.7557 2.279E-04 0.018197719 
Mrpl11 -0.9142 1.557E-04 0.014316035 
Mrpl18 -0.5489 4.180E-06 0.001007875 
Mrpl37 0.5029 9.582E-04 0.047603974 
Mrpl41 -1.2250 5.800E-05 0.007030782 
Mrpl52 -0.9241 4.670E-04 0.029456446 
Mrpl57 -0.7498 1.593E-04 0.014316035 
Mrps14 -1.2231 9.280E-11 2.71E-07 
Mrps28 -0.9644 5.423E-04 0.032208661 
Ms4a4c -0.8284 1.414E-04 0.013646282 
Msh4 5.6446 6.980E-05 0.008058411 
Mtfp1 -2.2271 9.314E-04 0.047094098 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Myd88 -1.7156 2.800E-05 0.004122366 
Myeov2 -1.5296 2.260E-11 9.49E-08 
Myom1 -2.4360 3.050E-05 0.00445408 
Mzb1 -0.6029 4.450E-05 0.005982602 
N6amt1 0.8526 1.480E-07 9.33E-05 
Naa40 0.5983 1.924E-04 0.016183437 
Nab2 0.7146 1.440E-04 0.013698763 
Naprt -1.3595 9.318E-04 0.047094098 
Ndufa1 -1.0844 1.850E-06 0.00058173 
Ndufa11 -1.1860 8.440E-08 5.98E-05 
Ndufa13 -0.8980 4.230E-06 0.001010246 
Ndufa2 -0.9127 1.578E-04 0.014316035 
Ndufa3 -0.9147 7.280E-05 0.008187189 
Ndufa6 -1.0083 4.720E-04 0.029544915 
Ndufb5 -0.7293 1.782E-04 0.015619555 
Ndufb9 -0.8765 5.416E-04 0.032208661 
Ndufc1 -1.2590 4.409E-04 0.028623241 
Ndufs4 -0.7539 2.101E-04 0.017126599 
Ndufs6 -1.1416 1.590E-05 0.002608299 
Nedd8 -0.9852 1.860E-06 0.00058173 
Nnat 4.0976 8.940E-08 5.98E-05 
Noc2l 0.7132 1.586E-04 0.014316035 
Nop10 -1.1869 1.380E-05 0.002415011 
Nploc4 0.4202 5.285E-04 0.031791045 
Nr1d1 6.5400 9.551E-04 0.047603974 
Nsfl1c -0.5622 5.772E-04 0.033549234 
Nsmce1 -0.8671 1.590E-05 0.002608299 
Nsmce2 -0.5926 5.559E-04 0.032774406 
Nsun6 -0.8160 4.576E-04 0.029094005 
Nudt7 1.3019 1.004E-04 0.01058553 
Oas3 1.6097 2.960E-06 0.000786414 
Ost4 -0.7516 7.372E-04 0.039842021 
Pak6 4.0709 4.530E-05 0.006044397 
Papln 1.3124 8.420E-06 0.0016832 
Pard6a -2.2654 9.047E-04 0.046226851 
Parp12 4.8174 5.910E-04 0.034006058 
Pcdhgb7 7.3292 9.470E-05 0.010211046 
Pcdhgb8 7.6552 5.020E-06 0.001138243 
Pdcd4 -0.9480 2.280E-05 0.003537589 
Pdrg1 -0.8280 7.140E-05 0.008110238 
Per1 0.5855 1.080E-06 0.000388467 
Pfdn5 -0.9342 4.860E-05 0.006355132 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Pglyrp1 -1.3727 2.211E-04 0.017777615 
Phc2 0.7720 1.860E-05 0.002944154 
Phf1 0.8978 3.839E-04 0.026111812 
Pigo 0.6128 5.170E-05 0.006475261 
Pigt 0.5337 6.920E-06 0.001421219 
Pim1 1.0014 6.010E-07 0.000258235 
Pip4k2b 0.7778 2.440E-05 0.003706705 
Pithd1 -0.8423 3.480E-05 0.004990462 
Plac8 -1.2200 3.016E-04 0.022195652 
Plcd1 6.7731 4.588E-04 0.029094005 
Plec 0.6529 5.767E-04 0.033549234 
Pmf1 -0.6670 2.510E-05 0.003785935 
Polr1d -0.8250 4.230E-09 5.50E-06 
Polr2g -0.8581 1.210E-06 0.000421191 
Pon2 -0.5908 6.170E-05 0.00740491 
Ppa2 -1.1284 1.651E-04 0.014651942 
Ppdpf -0.8993 1.203E-04 0.012077273 
Ppp1r13l 1.9110 2.198E-04 0.017732791 
Prdx5 -1.1248 6.670E-05 0.007805941 
Prkch 5.7893 1.040E-06 0.000380619 
Prmt2 7.6606 2.300E-05 0.003537589 
Prpf4 0.5918 9.690E-05 0.010303263 
Psma1 -0.5857 2.758E-04 0.021094337 
Psma2 -0.4918 9.670E-05 0.010303263 
Psmb1 -0.6629 1.490E-05 0.002537713 
Psmb10 -0.8905 1.830E-07 0.000109906 
Psmb8 -0.5571 6.020E-08 4.69E-05 
Psme2 -0.7814 6.590E-08 4.82E-05 
Ptger1 1.0496 1.350E-05 0.002387967 
Ptges3l 3.4863 8.590E-06 0.001689613 
Ptpn3 3.9362 3.412E-04 0.024265385 
Ptprcap -0.8669 1.600E-06 0.000519161 
Puf60 -0.5827 8.156E-04 0.043329649 
Qtrtd1 0.7433 1.801E-04 0.015727098 
Rabac1 -1.3877 4.948E-04 0.030386385 
Rad51c 0.5694 1.579E-04 0.014316035 
Rag1 -8.3703 6.460E-05 0.007598937 
Rasal3 0.4516 4.550E-05 0.006044397 
Rbm38 0.4478 1.458E-04 0.013698763 
Rbm44 -2.2297 2.720E-14 6.36E-10 
Rbms2 0.6455 1.326E-04 0.013063631 
Rbx1 -0.7696 2.768E-04 0.021101396 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Rcc1 0.4691 1.423E-04 0.013646282 
Retsat 2.5250 1.120E-06 0.000395938 
Rfc3 -0.4219 8.364E-04 0.044081825 
Rgs7 4.3554 6.790E-06 0.001418467 
Rilpl2 -1.3288 1.451E-04 0.013698763 
Rnf213 0.4807 9.571E-04 0.047603974 
Rnf219 -0.6905 4.300E-07 0.000211301 
RP23-102B12.2 1.7814 4.428E-04 0.028623241 
RP23-264E23.1 6.9990 5.891E-04 0.034006058 
RP23-323E20.2 2.2708 5.016E-04 0.030646583 
RP23-328J8.3 0.6053 7.073E-04 0.038850306 
RP23-395G18.1 6.5192 3.250E-04 0.023472429 
RP23-456B9.18 2.5842 4.130E-06 0.001006441 
RP23-98F21.12 6.7000 1.813E-04 0.015772248 
RP24-271M20.4 0.8163 1.500E-05 0.002537713 
RP24-337A16.2 3.1043 4.720E-07 0.000218413 
RP24-338G10.1 0.9055 5.260E-07 0.000232157 
RP24-490B17.7 3.7508 3.660E-06 0.000914093 
RP24-546N2.2 0.8876 5.080E-05 0.00646751 
RP24-74O18.2 1.1618 5.050E-08 4.22E-05 
RP24-87I22.4 6.4477 4.195E-04 0.027808794 
RP24-88B13.5 1.9255 1.061E-04 0.011029589 
RP24-92E18.2 6.5864 5.239E-04 0.031680477 
RP24-93F24.2 4.1442 4.340E-06 0.001024702 
Rpa3 -0.9530 3.133E-04 0.022837157 
Rpl13a -0.9367 7.160E-07 0.000288717 
Rpl14 -1.0443 2.880E-06 0.000783828 
Rpl18 -0.7698 1.925E-04 0.016183437 
Rpl18a -1.0521 1.550E-06 0.00050972 
Rpl22 -0.7930 8.380E-07 0.000326826 
Rpl23 -0.9741 1.310E-06 0.00044925 
Rpl26 -0.8778 4.322E-04 0.02848664 
Rpl29 -0.9042 3.230E-05 0.004696993 
Rpl29-ps1 4.6712 3.540E-04 0.024872335 
Rpl32 -0.7027 4.686E-04 0.029479146 
Rpl34 -0.9658 2.310E-05 0.003537589 
Rpl35a -0.8442 1.400E-06 0.000466495 
Rpl37 -1.3331 6.030E-06 0.001283323 
Rpl37a -0.9193 2.575E-04 0.020081536 
Rpl39 -1.3013 3.900E-05 0.005434638 
Rpl41 -0.8306 7.550E-05 0.008448902 
Rpl8 -0.7389 6.070E-07 0.000258235 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Rplp0 -0.5916 5.702E-04 0.033437458 
Rplp1 -1.1920 1.610E-05 0.002608299 
Rplp2 -0.7706 5.972E-04 0.034167518 
Rps10 -1.1858 2.730E-09 3.80E-06 
Rps11 -0.7032 8.664E-04 0.045054292 
Rps15 -0.6246 5.233E-04 0.031680477 
Rps15a -0.7338 3.930E-05 0.005445758 
Rps18 -0.5429 9.310E-05 0.01013161 
Rps19 -0.7958 2.370E-09 3.69E-06 
Rps20 -0.8948 4.890E-05 0.006361927 
Rps25 -0.8144 1.010E-05 0.001924218 
Rps26 -1.2162 2.630E-06 0.000742214 
Rps28 -1.0982 5.140E-05 0.006467641 
Rps3 -0.6728 4.420E-07 0.000211301 
Rps3a1 -0.8900 6.920E-05 0.008051088 
Rps4x -0.7095 1.714E-04 0.015134516 
Rps5 -0.5833 3.185E-04 0.023075185 
Rps6ka1 0.4278 9.793E-04 0.048445584 
Rps6kb2 0.6940 3.920E-06 0.000965421 
Rps8 -0.8121 9.432E-04 0.047565342 
Rtp4 2.7631 3.330E-04 0.023899449 
Sdc4 -1.3695 1.550E-07 9.53E-05 
Sec11c -0.3822 8.995E-04 0.046156686 
Sec14l1 0.6263 8.240E-05 0.009094634 
Sec61b -1.1638 1.600E-05 0.002608299 
Sema7a 0.3681 5.335E-04 0.031897477 
Serpinc1 5.2825 2.984E-04 0.022097454 
Shfm1 -1.0192 4.160E-05 0.005728064 
Sipa1l3 0.6365 9.833E-04 0.048540178 
Skap2 -0.6163 4.410E-05 0.005982602 
Slc12a3 1.3302 5.070E-05 0.00646751 
Slc22a23 2.4067 4.442E-04 0.028633884 
Slc25a3 -0.3671 6.280E-05 0.007460177 
Slc30a4 0.8651 4.857E-04 0.030067093 
Slc39a13 0.7242 1.858E-04 0.015983646 
Slc6a6 0.7102 4.390E-07 0.000211301 
Slc9a8 0.4852 6.250E-05 0.007460177 
Smdt1 -0.7615 2.543E-04 0.019925951 
Snrpb2 -0.7427 3.100E-06 0.000808821 
Snrpg -1.1458 1.420E-04 0.013646282 
Snx3 -0.6313 8.010E-05 0.008882859 
Sod1 -1.0827 3.190E-12 1.87E-08 
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Gene 
KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Sptb 6.8808 3.362E-04 0.023983793 
Srp19 -0.4994 1.869E-04 0.016023916 
Srsf9 -0.7185 7.450E-06 0.001515866 
Stk16 -0.7760 1.070E-05 0.001968641 
Stk35 0.5204 8.939E-04 0.045973334 
Stpg1 6.5747 6.148E-04 0.034749528 
Stra13 -1.0078 5.760E-06 0.001259633 
Strn4 0.7164 6.010E-06 0.001283323 
Sub1 -1.5856 1.190E-09 1.99E-06 
Sv2b -4.1621 2.530E-07 0.000144311 
Sync 6.7751 9.179E-04 0.046692079 
Syngr2 0.6606 2.760E-05 0.004082412 
Tbc1d4 1.3563 4.934E-04 0.030385557 
Tbca -1.0437 5.900E-05 0.007119252 
Tbrg4 0.5565 1.930E-04 0.016183437 
Tceb1 -0.6888 2.148E-04 0.017389765 
Tcf7 1.5659 1.460E-05 0.002514129 
Tcp11 6.7363 6.375E-04 0.03594709 
Tet3 0.3712 1.185E-04 0.012004012 
Tmed9 -0.4972 3.911E-04 0.026523908 
Tmem120b 1.9406 1.306E-04 0.012951588 
Tmem136 4.3659 2.882E-04 0.02189904 
Tmem14c -0.8568 2.010E-07 0.000117315 
Tmem259 0.5680 2.939E-04 0.022034196 
Tmsb4x -0.8788 3.752E-04 0.025834217 
Tnk2os 7.4300 1.190E-05 0.002169958 
Tomm7 -1.1319 2.611E-04 0.020232397 
Traf4 0.8896 3.730E-05 0.005271163 
Trappc1 -0.7412 5.090E-05 0.00646751 
Trbc2 1.8712 2.702E-04 0.020794843 
Trbv13-2 6.6686 9.983E-04 0.048871902 
Trp53i13 1.8640 4.045E-04 0.027046227 
Trpm4 2.2614 1.921E-04 0.016183437 
Tstd3 -0.7534 5.344E-04 0.031897477 
Ttbk1 7.5687 5.440E-05 0.006695136 
Ttc26 6.5280 5.254E-04 0.031686164 
Txn1 -0.7871 4.490E-06 0.001049821 
Ubr4 0.4378 1.510E-05 0.002547635 
Uqcr10 -0.7589 1.036E-04 0.010823153 
Uqcrh -1.0670 7.380E-09 8.22E-06 
Uqcrq -1.1135 1.329E-04 0.013063631 
Use1 -0.9520 2.760E-09 3.80E-06 
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KOvsWT 
.log2FC KOvsWT.RawP KOvsWT.FDR 
Usp19 0.4495 9.471E-04 0.047603974 
Usp30 0.8678 6.038E-04 0.034376873 
Utrn 1.0442 1.018E-04 0.010679699 
Vasp -0.6681 4.450E-05 0.005982602 
Vpreb3 -1.1381 1.100E-09 1.98E-06 
Vsig10l 2.6839 4.014E-04 0.026960996 
Wdr31 3.9940 7.050E-05 0.008073327 
Wrnip1 -0.7507 6.435E-04 0.036199004 
Xdh 4.5193 1.578E-04 0.014316035 
Xlr3b -2.6180 3.045E-04 0.022294947 
Xpo6 0.3132 7.159E-04 0.039140118 
Ywhaq -0.7769 3.343E-04 0.023925901 
Zc3h12c -1.9522 8.523E-04 0.044617056 
Zeb2 -1.0680 1.126E-04 0.011553694 
Zfp180 0.5798 4.260E-05 0.005832368 
Zfp365 2.7412 2.190E-08 2.13E-05 
Zfp366 7.6177 1.832E-04 0.015822329 
Zfp704 7.5681 1.040E-05 0.001968641 
Zfp951 1.9242 7.069E-04 0.038850306 
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